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ABSTRACT
ESSAYS ON SMOKING, DRINKING, AND OBESITY: EVIDENCE FROM A
RANDOMIZED EXPERIMENT
BY
BENJAMIN DAVID THOMAS JOHANNES UKERT
August 2016
Committee Chair: Dr. Rusty Tchernis
Major Department: Economics
This dissertation consists of three chapters analyzing risky health behaviors utilizing data from
the Lung Health Study (LHS), a randomized smoking cessation program. The first two chapters of
this dissertation analyze the effects of smoking on alcohol consumption and BMI, respectively. The
third chapter studies whether and how much the objective smoking information, which is defined
by clinicians, may be misreported.
The first chapter examines the effect of smoking on alcoholic beverage consumption. The
epidemiology literature suggests that both behaviors affect similar brain regions and are commonly
consumed together. So far, the economics literature has presented inconclusive causal evidence on
the relationship. Building on the theory of rational addiction, I estimate the relationship between
smoking and alcohol consumption using several different smoking measures. I report four salient
findings. First, self-reported and clinically verified smoking variables suggest that quitting smoking
lowers alcoholic beverages consumption by 11.5%. Second, cigarette consumption dating back 12
months affects alcohol consumption, and those with the highest past 12 months average cigarette
consumption see the largest increase in alcohol consumption. Third, I find that the length of quitting
affects future alcohol consumption as well. Continuously abstaining from smoking for 12 months
reduces alcoholic beverage consumption by 27.5% per week. Fourth, non-smoking for 12 months
also reduces the probability of drinking any alcoholic beverages by 31%.
The second chapter aims to identify the causal effect of smoking on body mass index (BMI).
Since nicotine is a metabolic stimulant and appetite suppressant, quitting or reducing smoking could

lead to weight gain. Using randomized treatment assignment to instrument for smoking, we estimate that quitting smoking leads to an average long-run weight gain of 1.8-1.9 BMI units, or
11-12 pounds at the average height. These results imply that the drop in smoking in recent decades
explains 14% of the concurrent rise in obesity. Semi-parametric models provide evidence of a diminishing marginal effect of smoking on BMI, while subsample regressions show that the impact
is largest for younger individuals, females, those with no college degree, and those with healthy
baseline BMI levels.
The third chapter analyzes and compares self-reported and clinically verified smoking information. Descriptive statistics show that about 8% of clinically verified smokers self-report that
they do not smoke (under-report participation), and that smoking cessation treatment group participants misreport smoking participation 2 to 1 relative to control group participants. In our first
methodological approach we regard the objectively verified smoking measure as the gold standard.
We estimate linear probability models and find that being male and married increases the probability of misreporting by 10 percentage points. Additionally, older participants are more likely to
misreport smoking status, while those using nicotine gum and with a higher BMI are less likely
to misreport. However, all variables can only explain a small fraction of the variation that explains misreporting. Our second methodological approach takes an agnostic view on whether the
clinically verified smoking information is accurate. We utilize BMI, Carbon Monoxide (CO), and
Cotinine level information to inform whether a person is a smoker. We estimate a Bayesian mixture
model to account for the heterogeneity in BMI, CO and Cotinine levels after a substantial decrease
in post treatment smoking participation. All of our models show that smokers are more likely assigned to the low BMI, high CO and high Cotinine level distributions. Among those classified
as misreporters, we find that 30% have a very high probability of being part of the non-smoking
distributions. As a result, we believe that objectively- verified smoking measure may not be better
than the self-reported measure.
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Introduction
During the early 20th century, smoking was a conventional habit across social classes in the United
States. Tobacco consumption was considered a regular good. For example, R.J.Reynolds advertised with this slogan: “More doctors smoke Camels than any other cigarette” (Gardner & Brandt
2006). As a consequence, by the mid 1960s smoking participation peaked at 42% among adults.
However, smoking participation has decreased every year since 1965. What caused the change?
One possible explanation is that smoking was not associated with health risks until the 60s. The
1964 surgeon general report is the first official statement summarizing the health risks associated
with smoking. Today, smoking is regarded as a health risk. According to the 2014 surgeon general
report, smoking accounts for 90% of all lung cancer deaths and 80% of all chronic obstructive
pulmonary disease (COPD) deaths. Moreover, the risk of dying from smoking increased within
the last 50 years among smokers (Thun et al. 2013).
The recognition of health risks associated with smoking prompted federal, state and local governments to impose smoking restrictions. Some of the steps taken by policymakers to reduce smoking include increasing cigarette taxes, introducing workplace smoking bans and requiring tobacco
free zones. Subsequently smoking prevalence decreased by roughly 20 percentage points from the
mid 70s.
Unfortunately, imposing smoking restrictions can result in severe unintended consequences.
Evidence suggests that higher cigarette prices lead to a higher BMI and obesity rate (Chou et al.
2004). Therefore, the overall health benefit from quitting smoking can be overstated if it does
not include the health risks associated with a potentially higher BMI. However, recent evidence
(Courtemanche 2009, Wehby et al. 2012) suggests that higher cigarette costs lower BMI. Thus, the
precise impact of cigarette cost on BMI remains controversial.
In addition, smoking restrictions may also affect alcoholic beverage consumption. Cigarette
consumption and alcohol consumption are highly correlated (Bobo et al. 1987, Grant et al. 2004),
but the literature is inconclusive on the causal relationship. If alcohol consumption and cigarette
consumption are complements, smoking restrictions would decrease alcohol consumption as well.
1

Therefore, the overall health benefits of quitting smoking are understated, as the benefits of lower
alcohol consumption are ignored.
My dissertation uses a randomized smoking cessation study, Lung Health Study (LHS), to investigate the effect of smoking on BMI and alcoholic beverage consumption. My first chapter
analyzes the causal relationship between smoking and alcoholic beverage consumption. I provide
evidence that smoking and alcohol consumption are positively correlated. My paper differs from
the previous literature in several ways. First, I estimate the relationship along the intensive and
extensive margin of smoking. Second, the LHS, a five-year panel study, allows me to look at the
effect of smoking in the short- and long-run. Third, I estimate a causal relationship at the individual level between cigarette consumption and alcoholic beverage consumption over-time. My main
results suggest that quitting smoking lowers the alcoholic beverage consumption by half a drink
per week. The effect is stronger the higher the cigarette consumption in the past, and the effects
persist over five years.
My second chapter evaluates the relationship between smoking and BMI. The chapter is the
result of co-authored work with Dr. Charles Courtemanche and Dr. Rusty Tchernis. We estimate
the effects along the intensive and extensive margin of smoking. We further provide evidence that
Eisenberg and Quinn (2006), who apply the same data, overestimate the effect of quitting smoking
on BMI. Lastly, we present evidence that quitting smoking not only reduces BMI, but that the effect
of smoking on BMI depends mostly on the intensity of smoking.
My third chapter has compares self-reported to objectively clinically verified smoking information provided in the LHS, by generating a misreporting measure captured difference between
both smoking variables. The first methodological approach regard the objectively verified smoking
measure as the gold standard, and we estimate linear probability models and find that being male
and married increases the probability of misreporting. However, all variables can only explain a
small fraction of the variation that explains misreporting. The second methodological approach
takes an agnostic view on whether the clinically verified smoking information is accurate. We utilize BMI, Carbon Monoxide (CO), and Cotinine level information to inform whether a person is a

2

smoker. All of our models show that smokers have a lower BMI, high CO and high Cotinine level.
However, all models also show that many misreporters are similar to non-smokers in characteristics
affected by smoking, allowing us to conclude that the objectively verified smoking measure may
not clearly identify smokers from-non-smokers.

3

I

The Effect of Smoking on Alcohol Consumption

Introduction
Smoking cigarettes is the leading cause of preventable deaths in the U.S., causing roughly 480,000
deaths per year (Center for Disease Control (CDC) 2012). It is well known that smoking causes
diseases such as lung cancer, stroke, coronary heart disease, and chronic obstructive pulmonary
disease (COPD).1 Despite a 50% decrease in smoking prevalence since the 1960s, an estimated
42 million U.S. adults smoke, generating roughly $289 billion per year in smoking related costs
(CDC news release 2014). Similarly, short- and long-term risks of excessive alcohol use, defined
as 15 or more drinks per week or 5 or more drinks per session for men, the third largest modifiable
risk factor in the U.S., include injuries, violence, dementia, stroke, and liver disease. Currently,
economic costs of excessive alcohol consumption account for about $249 billion per year (Sacks
et al. 2015).
Given the severe consequences of both risky behaviors, understanding how they influence each
other is an important policy question. A large health literature suggests that smoking and drinking
are highly correlated (Bobo et al. 1987, Bobo et al 2000, Bien et al. 1990). Increasing cigarette
taxes or expanding smoking ban regulation may induce smoking cessation, but could increase
drinking if they are substitutes. Therefore, the net health benefits of quitting smoking would be
overstated, as the costs of higher alcohol consumption are ignored. On the other hand, if quitting
smoking reduces drinking, the benefits of quitting smoking would be understated.
In this paper I exploit a randomized smoking cessation study, the Lung Health Study (LHS),
to investigate the relationship between cigarette smoking and alcohol consumption. My empirical
strategy uses the randomized intervention assignment as an instrumental variable for smoking. This
allows me to estimate a causal effect and analyze the effect of smoking on alcohol consumption
along the intensive and extensive margin. Additionally, I also analyze the effect by gender, marital
status, and among excessive alcohol users.
1

Surgeon General Report 2015.

4

This paper contributes to two strands of economic literature: First, it provides new evidence
on the causal relationship between smoking and drinking. The typical approach to identify complementarity or substitutability is to regress consumption levels of one good on the price of the
other good. However, the current literature report inconclusive results on the relationship between
smoking and drinking.2 Cameron and Williams (2001) and Bask and Melkersson (2004) find complementarity between smoking and drinking in both alcohol and cigarette demand equations, others,
such as Goel and Morey (1995) and Picone et al. (2004), find that smoking and drinking are substitutes. Additionally, Decker and Schwartz (2000) find complementarity in a cigarette demand
equation and substitutability in an alcohol demand equation.3 I find that quitting smoking reduces
alcohol consumption, implying both goods can be complements in consumption.
Second, I contribute to a growing literature on habit formation that tests how past cigarette
consumption, also known as the smoking habit stock, affects current consumption of alcohol or
other addictive goods (Goel and Morey 1995, Pacula 1997, 1998, Kenkel et al. 2001). Becker and
Murphy’s (1988) rational addiction model provides a formal theoretical framework that Bask and
Melkersson (2004) extend to two addictive goods and then show that, depending on the interaction
between both addictive goods, quitting one addictive good can increase or decrease the overall
consumption of another addictive good in the future. To date, there is mixed and limited empirical
evidence on the effect of past smoking on current alcohol consumption (see Bask & Melkersson
2004, Picone et al. 2004, and Pierani et al. 2009). I provide evidence that a smoking habit stock,
measured by up to 5 years of historic smoking decisions, increases current alcohol consumption.
I also show that the effect of the smoking habit stock on alcohol consumption is larger among
heavy smokers. Lastly, I show that those who permanently abstain from smoking longer consume
2

For a general overview on the literature see Pierani et al. (2009).
The application of different data and identification strategies may be an explanation for the empirical different
results among similar demand equations. For example, Bask and Melkersson (2004) use aggregate time series sales
volume data from Sweden and estimate demand equations based on the rational addiction model. Picone et al. (2004)
rely on individual level data from the Health and Retirement Survey (HRS) and apply an instrumental variable approach, using prices and lagged consumption as instruments for current consumption. Whereas Decker and Schwarz
(2000) concentrate on the estimation of the relationship between cigarette and alcohol prices on alcohol and cigarette
consumption levels, respectively. Another reason for the diverse results could be that the price variation is not exogenous.
3
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considerable less alcohol.
Overall, I conclude that cigarettes and alcohol are positively correlated. Quitting smoking leads
to a reduction of alcoholic beverage consumption by 11.5% per week.4 Restricting the sample
to unmarried smokers shows that quitters reduce alcohol consumption by 16%. Similarly, when
looking at the sample of excessive alcohol users, defined as consuming 15 or more drinks per
week or 5 or more drinks per session, quitting smoking reduces alcohol consumption by roughly
11% per week.5 Excessive male drinkers reduce alcohol consumption by 14% drinks per week after
quitting smoking, while excessive female drinkers do not reduce alcohol consumption after quitting
smoking.6
Results also suggest that the habit stock of cigarettes affects current alcohol consumption significantly. Both the intensity and length of smoking significantly affect current alcohol consumption.
Consuming on average 20 cigarettes per day in the past year increases current alcohol consumption by 28% from the mean baseline alcoholic beverage consumption level. Similarly, those who
quit smoking 12 months ago, whether successful or not, decrease current alcoholic beverage consumption by 20% per week while also decreasing the probability of drinking any alcohol by 20%.
Abstaining from smoking continuously for 12 months leads to 27.5% fewer consumed drinks per
week and decreases the probability of any drinking by 30%. The effects of permanently quitting
for 12 months are particularly pronounced for women who reduce alcohol consumption by roughly
53% vs. 23% for men.
The rest of the paper is organized as follows. The next section provides a summary of the
conceptual framework. Section 3 discusses the data. Section 4 outlines the estimation strategy.
Section 5 presents the results. Section 6 concludes.
4

11.5% equal about 0.5 drinks per week on an average pre-treatment consumption of 4.35 drinks per week.
11% translates into 1.6 drinks per week.
6
On average Excessive male drinkers consume 15 drinks per week pre-treatment. Males reduce alcohol consumption by 2.1 drinks per week.
5
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Conceptual Framework
This section discusses a simple conceptual framework on the relationship between smoking and
alcohol consumption. We formulate the framework by taking advantage of the medical literature documenting in many cases a positive correlation between smoking and alcohol consumption
(Carmelli et al. 1993, Enoch et al. 2001, Swan et al. 1997). The Supplement outlines in detail the
theoretical implications for a model of addiction with two addictive goods. The outlined framework considers a utility maximizing agent, and builds its foundation on the rational addiction model
by Becker and Murphy (1988), and Bask and Melkersson (2004). Consider an individual making
two simultaneous decisions: whether to consume alcohol and cigarettes, and the quantity of each
good. For simplification the individual does not maximize his lifetime utility, i.e. the individual
is myopic, and we assume complementarity between smoking and drinking. Opposite conclusions
will be drawn for the case of substitutability.
The Supplement presents two conclusions. First, the choice of quitting smoking immediately
decreases the consumption of alcoholic beverages. Complementary assumes that consuming both at
the same time also raises the marginal utility of both good. Thus, choosing not to consume cigarettes
will reduce the marginal utility of consuming alcoholic beverages. Formally, marginal utility must
equal marginal cost, and a reduction in the marginal utility of alcoholic beverages requires a decrease in consumption to satisfy the equality, ceteris paribus. Therefore, quitting smoking will
reduce alcohol consumption.
Second, quitting smoking will reduce alcohol consumption over-time. The habit stock, a function of past smoking and beverage consumption, increases the marginal utility of smoking and
also increases the marginal utility of alcoholic beverage consumption. The epidemiology literature
presents evidence supporting the aforementioned response to a change in the habit stock, as smoking increases the nicotine intake affects the limbic system. Barrett et al. (2006) show that nicotine
increases dopamine output and higher dopamine levels lead to an increased craving for alcoholic
beverage consumption. Similarly, the consumption of cigarettes increases a person’s familiarity
with its psychological and physical benefits and contributes to habit formation, resulting in an in7

creased desire to consume additional cigarettes and can spill over to alcohol consumption as well.
The influence of past physical and psychological experience on today’s behavior is summarized in
the form of the habit stock.
Similarly, a large literature on youth addictive behavior shows that the consumption of legal
addictive goods leads to future consumption of other legal and illegal addictive goods. The experience of ones addictive good consumption generates a benefit that can increase over time, and affect
the enjoyment of other addictive goods (See for example Pacula 1997 & 1998, Kenkel et al. 2001).
Put differently, today’s consumption depends on the habit stock. The longer someone smokes, the
higher the habit stock, while quitting smoking depreciates the habit stock over-time. The level of
the habit stock directly affects the marginal utility of alcohol consumption.7
In summary, the framework outlines the relationship between past and current smoking behavior on current alcohol consumption. Quitting smoking will cause two distinct changes in the
marginal utility of alcoholic beverage consumption. First, quitting smoking decreases immediately
the marginal utility of alcohol consumption, leading to lower alcohol demand. Second, quitting
smoking decreases the marginal utility of alcohol consumption over time through a depreciation of
the habit stock. Again, leading to a reduction in alcoholic beverage consumption.

Data
I utilize data from the Lung Health Study (LHS), a randomized smoking cessation trial implemented
to measure the effect of smoking cessation on lung function. O’Hara et al. (1993, 1998) present a
comprehensive analysis of the LHS recruitment and implementation. I briefly summarize the most
important aspects relevant to the paper. Recruitment took place between 1986 and 1989 within a
wide region of the 10 hospitals (9 in U.S. and 1 in Canada) participating in the study.8 Participation
7

In a broader economic context, the habit stock of smoking has similar properties to the concept of human capital
stock in labor economics (Ben-Porath 1967). Education, training, and work experience increase the total human capital
stock, which improves productivity and consequently wages. Similarly, the human capital stock depreciates over time,
mostly due to age. Depreciation can be stopped or at least minimized by consistent investments into education or
training. The habit stock of cigarettes can be thought of in a similar fashion, replacing education, training and work
with cigarette consumption and productivity with smoking appreciation.
8
Participants should live no more than 75 miles away from the hospital and should have no intentions to move
away from the area. This requirement was implemented to minimize attrition. The list of hospitals participating can
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required applicants to be 35 to 59 years old, show signs of mild lung function impairment, have
no history of certain medications, consume less than 25 alcoholic beverages per week.9 , have no
severe illnesses, and have no chronic medical conditions.10 After 3 screening interviews the final
study samples included 5887 participants.11
After recruitment, participants were randomly assigned into three different groups, two treatment groups that include smoking cessation treatment with an inhaled placebo (SI-P) and smoking
cessation treatment with an inhaled bronchodilator (SI-A) and a control group receiving no treatment (UC). The only difference in treatment between the SI-P and SI-A group were that the SI-A
group received an inhaler with ipratropium bromide to treat early COPD symptoms, while the SI-P
group received a placebo inhaler. Both treat treatment groups, SI-A and SI-P, also received nicotine gum prescriptions, an intensive 12 session quit week accompanied by frequent contact with
support personal, and invitations to bring a spouse or relative to the meetings. The usual care group
received no treatment. Most of the treatment was completed within the first 4 months of the study
and there was no differential effect on smoking cessation for the SI-P and SI-A treatment group
members.
All participants were interviewed individually at a medical clinic near the residence of the participant to collect information about average alcoholic beverage consumption, weight, age, gender,
employment status, smoking behavior, type of tobacco use and family smoking habits. Concerns
about measurement error in cigarette consumption as well as smoking status can be minimized
given that smoking status is annually verified by clinicians through carbon monoxide and cotinine
level tests at each of the annual follow-up visits. For the empirical analysis I use the objectively
verified binary smoking measure, the continuous carbon monoxide measure, and monthly information on self-reported cigarette consumption per day. The results section presents mostly regression
outputs for the annual verified smoking status and the monthly self-reported smoking variables. In
be found online http://www.biostat.umn.edu/lhs/centers.html
9
The alcohol limit was only implemented for the first third of the recruitment process and deleted afterwards.
10
History of certain medication use includes medicine for tuberculosis, theophylline or other xanthines, betablockers, insulin, any corticosteriods, antipsychotic drugs, nitroglyercine, digitalis, anticoagulants and antiarrhythmics.
Alcoholics were also excluded.
11
The clinical trial ended in 1994.
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any case, I draw similar empirical conclusions when I use the carbon monoxide measure.
The sample includes 6 years of data: one pre-treatment year and five post-treatment years. Table
1 presents descriptive statistics at the randomization meeting. At that time, the average alcoholic
beverage consumption was close to 4.3 drinks per week. Among the portion of the sample that
drinks alcohol, the average alcoholic beverage consumption was 6.3 drinks per week. The average
age of smokers was 48 and the average cigarette consumption per day was roughly 30 cigarettes per
day. Additionally, The survey does not collect information regarding income, but a high average
education level, at 13.50 completed years, allows me to assume that the average income level should
be higher than in the general population as well.12 The data does not have information on race, but
O’Hara et al. (1998) mention that the sample is 97% white.
Table 1: Summary Statistics at Randomized
Treatment Assignment Meeting
Variable
Drinks per week

SI-A
4.30
(5.57)
Age
48.41
(6.84)
Marital Status
0.65
(0.47)
Education
13.57
(2.83)
Male
0.61
(0.48)
Cigarettes per Day 29.59
(14.08)
Carbon Monoxide 25.97
(13.47)
Observations
1961

SI-P
4.39
(5.56)
48.55
(6.83)
0.67
(0.47)
13.56
(2.84)
0.64
(0.48)
29.49
(13.64)
26.70
(12.67)
1962

UC
4.36
(5.47)
48.43
(6.84)
0.65
(0.47)
13.68
(2.79)
0.64
(0.48)
29.53
(14.11)
25.98
(12.66)
1964

Standard deviation in parenthesis. SI-A, SI-P and UC
refer to the three treatment groups. Data collected at
time of randomized assignment to intervention groups.
Cigarettes per day represents the self-reported average
daily cigarette consumption of each participant. Education is measured in years of highest grade completed.
12

The 1990 NHIS suggest an average level 12.50 years of completed education.
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The summary characteristics in Table 1 are balanced across treatment groups and signify a
successful randomization. T-tests and F-tests confirm the hypothesis that the variable means are
not different across treatment group. Besides the reported variables presented in Table 1,participants are also asked about their average levels of cigarette consumption per day in every of the
past 12 months. Appendix Table A.1 presents the monthly smoking status and average cigarette
consumption per day surveyed at the first annual follow-up.
The LHS has two benefits relative to observational data. First, I have an objectively verified
smoking variable, reducing potentially the problem of mismeasurement relative to self-reported
information. Second, the data is randomized, allowing for causal inference. Due to the efforts to
retain contact with the participants, attrition rates were low. By the fifth annual follow-up visit at
the local clinic, 95 percent of men and 96 percent of women attended.13
Some limitations remain that are common across randomized control trials. The data consists of
smokers who responded to recruitment efforts to participate in a smoking cessation study. The selfselection indicates that the sample may not be representative of the general smoking population and
may result in estimates that have questionable external validity. With that said, the estimates may in
fact not be valid because the latest Surgeon General Report documents that almost 70% of current
smokers indicate that they would be willing to quit smoking. Thus, generally smokers are willing
to quit, but may be unable to quit without any support group or intervention (2014 Surgeon General
Report). Therefore, any inference may be at least attributable to 70% of the smoking population.

Estimation Strategy
The empirical strategy estimates the effect of smoking on alcoholic beverage consumption, conducts sub-sample analyses, and tests for differences in short- and long run effects. I identify the
relationship between smoking and drinking with two different models. First, I estimate whether
smoking and alcohol are complements in consumption. Second, I test how smoking in the past, the
habit stock of smoking, affects current alcohol consumption.
13

See O’Hara et al. (1998) for more details on attrition.
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The first model estimates cross-sectional regression between current smoking status and current
alcohol consumption at the first annual follow-up visit. The cross-sectional data from the first
follow-up visit should identify the short-term effect of quitting smoking on drinking. I begin my
analysis with OLS:

Drinksit = γ0 + γ1 Smokeit + Xi γ + µit

(1)

Where the dependent variable, Drinksit , represents alcoholic beverage consumption per week
for person i at the first follow-up visit, Smokeit is equal to an indicator for whether a person is a
current smoker and zero otherwise, a continuous cigarettes per day variable, or a measure of carbon
monoxide level, and Xi is a vector of demographic characteristics at baseline including age, gender,
education level, and marital status.
To generate exogenous variation in smoking, I utilize an instrumental variables approach, or a
two stage least square (2SLS) approach. The first follow-up visit allows me to apply the randomized
smoking cessation treatment as an instrumental variable, because treatment was received earlier in
the year. The approach allows me to analyze the causal relationship between both choices.14 The
appropriate first and second stages are presented here:

Smokeit = β0 + T reatmenti β + Xi β + ϵit
Second Stage:

ˆ it + Xi γ + ηit
Drinksit = γ0 + γ1 Smoke
Where T reatmenti represents a vector of two dummy variables equal to one for participants in each
of the smoking cessation programs and zero otherwise. The underlying assumption on the treatment
suggests that it is uncorrelated with the error term ηit , and highly correlated with smoking status.
14
I am unable to merge cigarette price data, because I have no state identifiers. This is the best I can do to understand
the contemporaneous relationship between cigarettes and alcohol.
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The random assignment to treatment allows for such a strong assumption. It is conceivable that the
treatment has a direct effect on drinking and violating the assumption of an uncorrelated error term
in the second stage. I test and reject that the treatment has a direct effect on drinking in the results
section. Therefore, the instruments should allow a2SLS estimation strategy to recover coefficients
that have a causal interpretation.
The second identification strategy estimates cross-sectional regressions between historic smoking measures and current alcohol consumption. Such regressions should identify the habit stock
effect of smoking on alcohol consumption. Based on the addiction theory and the literature, I include the previous period’s smoking status.15 Moreover, the benefit of the LHS is that it includes
detailed monthly self-reported historic smoking information. Thus, it allows me to estimate the
effect of historic smoking measures that are a function of monthly information on alcohol consumption. Those measures include dummy variables measuring the average intensity of cigarette
consumption in the last year, and also cumulative 12 months cigarette consumption variables with
and without some form of depreciation over-time. The general setup of the regression follows
equation (1) with the only difference being the inclusion of lagged smoking measures:

Drinksit = γ0 + γ1 Smokeit−1 + γ2 Xit + µit

(2)

All variables are exactly the same as defined in equation (11), except that smoking is some measure
of historic 12 months cigarette consumption. Where applicable, I use a 2SLS estimation strategy to
control for endogeneity. The instrument should yield be valid because treatment group assignment
was random and occurred at least 13 months prior to the information collected on cigarette consumption and alcoholic beverages. In both cases, I use the random assignment to smoking cessation
groups as a instrument for current and lagged smoking status.
I also estimate the effects of smoking on the probability of drinking, where I replace the lefthand side variable in (1)-(2) with a binary indicator equal to one if the person drinks alcohol and zero
otherwise. As a robustness check, I also estimate the relationship between smoking and drinking
15

See the Supplement that explains the theoretical background of the habit stock effect.
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with Negative Binomial (NB) models, because the dependent variable is a count variable with
an over-dispersed variance. Regular NB estimates will result in biased coefficients. I apply a
control function approach to account for endogeneity. NB control function approach estimates
are abbreviated with CF-NB. The approach includes the predicted residuals from the IV’s first
stage as an independent variable in the second stage. This is a commonly used approach for nonlinear correction for endogeneity.16 Lastly, I also estimate equation (11) with a log-transformed
dependent variable, where I generate log-drinks per week variable by adding a constant of one to
each observation before taking logs.
The results section presents estimates from OLS, 2SLS, NB, NB-CF, log, and log-2SLS models.
The 2SLS and control function estimates have a ‘causal’ interpretation under the assumption that
the instrumental variables have no direct effect on drinking. They estimate a local average treatment
effect (LATE). In other words, the causal effect estimates how a shock in cigarette consumption
induced by the intervention changes the level of alcohol consumption. Equation (1) estimates the
instantaneous effect of quitting smoking on alcohol consumption for those who received the treatment earlier in the year. Therefore, equation (1) implies a temporal relationship by definition of
the LATE, which I explore deeper with equation (2) where I estimate how past smoking decisions
affect current alcohol consumption. The latter equation is a first step at getting at the effect of the
smoking habit stock, because past quitters are less likely to smoke today.

Results
The Impact of Smoking on Alcohol Consumption
O’Hara et al. (1993) show that the smoking cessation treatment was effective in reducing smoking. I verify their results by presenting estimates for the first stage of the 2SLS approach. Table
2 presents marginal effects for the treatment variables and shows that the treatment was effective
in reducing smoking. Stock et al. (2002) provide evidence that large F-statistics indicate a strong
16

See Wooldridge, J. Econometric Analysis of Cross Section and Panel Data, 2nd Edition or Cameron, C. and
Travedi, P. Microeconmetrics Methods and Application
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instrument. In this case F-statistics are well above 10 in both regressions with and without demographic variables.
Table 2: First Stage Estimates between Smoking Cessation Treatment and
Smoking at the First Annual Follow-up Visit
First Stage IV Regressions
Verified Smoking Status
Dep. Var.
Smoke
Treatment (SI-A) -0.272***
(0.013)
Treatment (SI-P) -0.267***
(0.013)
Demographics
Yes
F- Stat
115.21
Observations
5,584
R-squared
0.0867

Carbon Monoxide
-8.014***
(0.464)
-7.782***
(0.470)
Yes
95.08
5,269
0.092

Self-Reported Smoking Status
Smoke
-0.322***
(0.014)
-0.311***
(0.014)
Yes
144.86
5,584
0.109

Cig. per day
-11.731***
(0.476)
-11.108***
(0.482)
Yes
125.98
5,584
0.134

Robust standard errors are in parenthesis. ***,**, and * indicate significance at the 1,
5, and 10 percent level. All first stages include demographic characteristics. Every row
entry represents a different regression on the dependent smoking status in year 1.
A concern remains regarding the validity of estimated coefficients from the 2SLS models.
Specifically, Courtemanche et al. (2015) show that including a dummy variable for smoking status is invalid in a 2SLS setup under the condition that the treatment affects smoking intensity, but
does not lead to smoking cessation. In other words, I have to test whether the instrument affects
drinking among those who do not change their smoking habits. A significant association suggests
that those who reduce cigarette consumption, but do not quit smoking, reduce alcohol consumption. This will lead to a biased estimator, because I would be unable to capture the reduction in the
intensive margin of smoking with the objectively verified smoking measure. I test this hypothesis
by running cross-sectional regressions and limiting the sample to subsets of smokers. First, I generate five post treatment sub-samples limiting the sample to objectively verified smokers in each
year. Second, in separate regressions, I limit the sample to individuals satisfying a non-sustained
quitter measure. The non-sustained quitter measure, which is only available for follow-up years 2
through 5, only includes individuals who smoke in at least one of the follow-up waves. All sub15

samples have very similar demographic characteristics to those presented in Table 1, with the only
difference that those participants did not quit smoking permanently. All tests should identify if the
treatment has an effect on those who temporarily change smoking status. Across both restrictions
and all regressions, I find no significant effects of the treatment on drinking.17 I conclude that there
is no evidence that the exclusion restriction is violated in the 2SLS model and that the estimator
should not be biased the objectively verified smoking dummy measure.
Next, I concentrate on the estimates on the effect of smoking on alcohol consumption from
equation (1). Table 3 provides marginal effects for OLS, 2SLS, NB, control function approach
NB, log, and log-2SLS estimates. Each coefficient in Table 3 represents estimates from a different
regression of equation (1). For comparison purposes, Table 3 presents the effect of smoking on
alcohol consumption for the objectively verified and self-reported smoking variables. Additionally, I also generate a quasi objectively-verified cigarette consumption measure and estimates yield
similar average effects of quitting smoking on drinking.18
The OLS and NB estimates suggest that those who quit smoking at the first annual visit consume
less alcohol than smokers. All results are significant at least at the 5% percent level. The OLS
results for the binary smoking variable reveal that smokers consume roughly half a drink more
than quitters, implying an increase of 11.5% from the mean alcoholic beverage consumption level
at randomization. Similarly, OLS results for the cigarettes per day variable present the same average
effect for an average smoker consuming 20 cigarettes per day. However, all 2SLS estimates are
insignificant, but present similar point estimates to the OLS results. There is good reason for the
insignificant but similar 2SLS estimates. In any 2SLS estimation standard errors increase from OLS
estimates. There is also a good reason why the coefficient does not change. The highly effective
smoking cessation program generates many non-smokers in the treatment group, but only few nonsmokers in the control group. Therefore, the variation in the OLS is very similar to the variation in
17

The reduced form results are not included. Results will be made available upon request.
I generate the quasi-objectively verified cigarette per day variable measure by comparing the verified smoking
status variable to the self-reported cigarette consumption per day. If the self-reported cigarette per day variable and
objective smoking dummy variable do not suggest the same smoking status, i.e. dummy variable indicates smoker
(equal to one), but self reported cigarette consumption measures equals zero. In all cases of mismatch I drop those
observations, leaving me with a quasi-objective cigarette measure.
18
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the 2SLS estimates. In other words, there is very little endogeneity.
Table 3: The Effect of Smoking on weekly Alcoholic Beverage Consumption
Negative Binomial

Obj. Verified Smoking Status:
Smoke
Carbon Monoxide
Observations

OLS
0.447**
(0.185)
0.020*
(0.010)
5584

2SLS
0.483
(0.741)
0.022
(0.026)
5584

Self-Reported Smoking Status:
Smoke
Cigs per Day
Observations

OLS
2SLS
0.633*** 0.420
(0.180) (0.630)
0.024*** 0.012
(0.006) (0.017)
5584
5584

NB
0.438**
(0.182)
0.015*
(0.008)
5584

CF-NB
0.524
(0.705)
0.023
(0.024)
5584

Log Drinks per Week
OLS†
0.038
(0.029)
0.0004
(0.001)
5584

2SLS†
0.099
(0.104)
0.003
(0.003)
5584

Negative Binomial

Log Drinks per Week

NB
CF-NB
0.585*** 0.476
(0.186) (0.581)
0.022*** 0.014
(0.005) (0.016)
5584
5584

OLS†
0.071***
(0.027)
0.0002**
(0.0008)
5584

2SLS†
0.085
(0.088)
0.002
(0.002)
5584

†

Coefficients in Columns 5-6 represent percentage change when multiplied by 100. On average a drinker
consumes 6.40 drinks per week.
Robust standard errors are in parenthesis. ***,**, and * indicate significance at the 1, 5, and 10 percent
level. All models include demographic characteristics. Every row entry represents a different regression
on the dependent variable, drinks per week, at the first annual follow-up visit. Log Drinks per Week
refers to regressions where the dependent variable is transformed into logs.
I also apply two approaches to identify if the OLS coefficient is biased. First, I test if nonsmokers differ from smokers in observable characteristics. If they do not differ in observable characteristics, it is less likely that they only differ in unobservable characteristics. There is no evidence
that smokers differ from non-smokers in observable characteristics. Second, I test for difference
in coefficients between OLS and 2SLS with the Hausman test. However, the Hausman test is not
valid for an endogenous dummy variable because the errors are not distributed normally. As a
result, I only apply the Hausman test for the non-reported cigarettes per day and carbon monoxide
variables. The hypothesis of the Hausman test is that OLS and 2SLS coefficients are equal to each
other cannot be rejected at the 10 percent level for all estimates. In other words, the endogeneity of
the OLS estimate is not strong enough to justify the use of 2SLS estimate with increased standard
17

errors.
Separately, I also run Probit and IV-Probit to estimate to understand if there are any extensive margin effects on drinking. Unreported Probit and IV-Probit estimates present no statistically
significant effect of quitting smoking on alcohol cessation.
Overall, I conclude that smokers consume more alcohol, implying that cigarettes and alcohol
are complements in consumption. However, significantly different effects of smoking on alcohol consumption for gender and socioeconomic status may persist. Previous studies support this
notion (See Pierani et al 2009, Picone et al. 2004) and the next subsection discusses sub-sample
differences.

Heterogeneous Effects
Smoking can have different effects by gender, age, and socioeconomic background. For example,
women are more easily addicted to cigarettes than men (See 2001 Surgeon General Report - Women
and Smoking). Genetic differences also cause women to absorb more alcohol and take longer
to metabolize alcohol. Therefore, this leaves women with higher alcohol levels in their blood
than men, conditional on drinking the same amount of alcohol. As a consequence, women are
more susceptible to alcohol’s long-term negative health effects than men (Ashley et al. 1977).
Married participants are exposed to a different household environment than singles that reduces
the likelihood of smoking and that reduces how often they report being in poor health (Schoenborn
2004).
Separately, sub-sample analysis among drinkers may be an important sample to analyze because
drinkers may be affected differently by the treatment cessation program than non-drinkers.19 Current drinkers and smokers may experience complementarity in consumption while non-drinkers
may experience substitutability. Therefore, quitting smoking may strongly reduce alcohol consumption among the sample consuming both, a result that may not be observable in the full sam19

Among the sample of drinkers at randomization, I tested for difference in demographic characteristics by treatment
groups and did not find any significant differences.
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ple.20 Initially, I tested the hypothesis that all coefficient are equal across gender and marital status
in Table 3, which was rejected at the 1 percent level. Moreover, the hypothesis that the coefficients
of smoking are equal across gender was rejected at the 10 percent level. While I was unable to
reject the null hypothesis of no difference in smoking across age, I include results for a sample
including people between 45 to 55 years old. The 45 to 55 age range may represent the longest
addicted smokers that are still receptive to quitting smoking while allowing for spillover effect in
alcohol consumption.
Table 4 presents sub-sample estimates for individuals who drink alcohol at randomization, by
gender, by marital status, and only for those between the ages of 45-55. The results are presented
in the same format as Table 3. All OLS results in column 1 present statistically significant results,
except for the sub-sample of individuals between the ages of 45-55. Given that the objectively verified smoking variable does not suffer from mis-measurement and present similar average effects
as the continuous smoking measure, I concentrate my discussion on those results. The effect of
smoking on drinking is larger in the sub-sample estimates of smokers who drink at the time of randomization than for the full sample estimates. The effect is also larger for males than females and
non-married participants relative to married participants. For example, among those who drink at
randomization, quitting smoking reduces alcohol consumption by 0.6 drinks per week. Moreover,
male smokers consume roughly 0.5 drinks more than non-smokers, and non-married smokers consume 0.7 drinks more than non-smokers. The coefficients in the female and married sub-sample
estimates are roughly half the magnitude than in the their counterpart male and non-married subsample regressions. Again, all 2SLS estimates are insignificant at the 10 percent level, but Hausman
tests suggest that OLS estimates can be utilized for all groups except for the age 45-55 sample.21
Overall, the OLS marginal effects present significant changes in average alcohol consumption
per week for several groups. For example, the mean baseline alcohol consumption among drinkers
20

I suspect that the full-sample results which includes some individuals who don’t drink at randomization, may result
in attenuated results towards zero.
21
I find that some sub-sample Probit estimates suggest that smoking decreases the probability of drinking by about
4-6%. IV-Probit estimates indicate no significant effect and present significantly different marginal effects. I conclude
that there is no effect on the extensive margin of drinking.
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Table 4: The Effect of Smoking on Weekly Alcoholic Beverage Consumption Among
Sub-Samples (Verified Smoking Variable Only)
Drinks at Baseline> 0
Smoke
Observations

OLS
2SLS
0.607*** 0.211
(0.235) (0.889)
3878
3878

Males
Smoke
Observations

OLS
0.520**
(0.261)
3491

2SLS
0.386
(1.028)
3491

Females
Smoke
Observations

OLS
2SLS
0.355*** 0.837
(0.227) (0.837)
2093
2093

Married
Smoke
Observations

OLS
0.343
(0.218)
3749

2SLS
0.578
(0.770)
3749

Not Married
Smoke
Observations

OLS
0.694**
(0.346)
1835

2SLS
0.334
(1.785)
1835

Age: Between 45-55
Smoke
Observations
†

OLS
0.239
(0.271)
2532

2SLS
1.971*
(1.014)
2532

Negative Binomial

Log Drinks per Week

NB
0.595***
(0.230)
3878

OLS†
0.060**
(0.030)
3878

CF-NB
0.321
(0.876)
3878

2SLS†
0.139
(0.108)
3878

Negative Binomial

Log Drinks per Week

NB
0.506*
(0.261)
3491

OLS†
0.034
(0.039)
3491

CF-NB
0.345
(1.035)
3491

2SLS†
-0.007
(0.132)
3491

Negative Binomial

Log Drinks per Week

NB
0.351
(0.222)
2093

OLS†
0.048
(0.042)
2093

CF-NB
0.768
(0.814)
2093

2SLS†
0.319*
(0.169)
2093

Negative Binomial

Log Drinks per Week

NB
0.338
(0.216)
3749

OLS†
0.028
(0.035)
3749

CF-NB
0.572
(0.735)
3749

2SLS†
0.061
(0.115)
3749

Negative Binomial

Log Drinks per Week

NB
0.661**
(0.334)
1835

OLS†
0.060
(0.052)
1835

CF-NB
0.534
(1.671)
1835

2SLS†
0.215
(0.223)
1835

Negative Binomial

Log Drinks per Week

NB
0.252
(0.263)
2532

OLS†
0.0264
(0.043)
2532

CF-NB
1.865**
(0.894)
2532

2SLS†
0.274*
(0.148)
2532

Coefficients in Columns 5-6 represent percentage change when multiplied by 100.
Robust standard errors are in parenthesis. ***,**, and * indicate significance at the 1, 5, and
10 percent level. All models include demographic characteristics. Every row entry represents
a different regression of the binary verified smoking variable on drinks per week in year 1. Log
Drinks per Week refers to regression estimates with a log transformed dependent.
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of 6.3 drinks per week suggests that quitting smoking reduces alcohol consumption by 10% for the
average drinker at baseline. The average level of alcohol consumption per week among male and
non-married smokers can be reduced by 11% and 16% if they quit smoking. Besides the demographic sub-samples, it is important to analyze the effect of quitting smoking among the excessive
drinking population alone. One might worry that the presented results are less important because
they concern moderate drinking levels. However, even at moderate levels of drinking the risk of
mortality increases significantly (Bouchery et al. 2006). Therefore, reducing moderate drinking
levels can significantly reduce the death toll. Since the cost of excessive drinking is extremely large
the next subsection concentrates on heavy and binge drinkers.

The Relationship Between Smoking and Drinking Among Excessive Drinkers
The Center for Disease Control (CDC) defines excessive drinking if someone is a heavy drinker,
defined as consuming 15 or more drinks per week for men, or binge drinker, defined as consuming
5 or more drinks per session per day for men. That group represent at least half the death toll
and three quarters of all costs associated with alcohol consumption alone (CDC 2016).22 Thus,
identifying the relationship between smoking and drinking is especially important among the highrisk population. Table 5 presents estimates for 4 different samples – a sample including heavy
drinkers consuming more than 14 drinks per week, a sample of heavy and binge drinkers defined
by the male standard, and samples of excessive drinkers by gender.
The estimates for the heavy drinking sub-sample do not suggest that quitting smoking reduces
alcohol consumption. However, the estimates are imprecise because of the small sample size.
The sub-sample including all excessive drinkers suggests that quitting smoking reduces alcohol
consumption by 1.68 drinks per week. The OLS coefficient is statistically significant at the 10 %
level, while the 2SLS estimates present insignificant results. Hausman tests do however indicate
that OLS estimates are preferred to 2SLS. Among the sample of excessive male drinkers, the OLS
estimates suggest that quitting smoking reduces alcohol consumption by 2 drinks per week. 2SLS
22

Heavy drinking for females is defined as consuming more than 7 drinks per week and binge drinking as consuming
more than 3 drinks per occasion.
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Table 5: The Effect of Smoking on Weekly Alcoholic Beverage Consumption among
Excessive Drinkers (Verified Smoking Variable Only)
Heavy Drinkers>14
Smoke
Observations

OLS
1.106
(1.170)
347

2SLS
-1.932
(5.622)
347

Excessive Drinkers
Smoke
Observations

OLS
1.68*
(0.885)
591

2SLS
-0.500
(4.114)
591

Male Excessive Drinkers
Smoke
Observations

OLS
2SLS
2.124** 2.117
(1.023) (4.535)
472
472

Female Excessive Drinkers
Smoke
Observations

OLS
-0.095
(0.695)
416

2SLS
-2.158
(2.991)
416

†

Negative Binomial

Log Drinks per Week

NB
1.100
(1.150)
347

OLS†
0.069
(0.100)
347

CF-NB
-1.867
(5.814)
347

2SLS†
-0.097
(0.416)
347

Negative Binomial

Log Drinks per Week

NB
1.513*
(0.877)
591

OLS†
0.132
(0.084)
591

CF-NB
-1.501
(4.658)
591

2SLS†
-0.254
(0.348)
591

Negative Binomial

Log Drinks per Week

NB
1.982*
(1.027)
472

OLS†
0.192*
(0.098)
472

CF-NB
1.818
(4.611)
472

2SLS†
-0.041
(0.372)
472

Negative Binomial

Log Drinks per Week

NB
0.039
(0.687)
416

OLS†
-0.021
(0.077)
416

CF-NB
-1.965
(3.767)
416

2SLS†
-0.067
(0.381)
416

Coefficients in Columns 5-6 represent percentage change when multiplied by 100.
Robust standard errors are in parenthesis. ***,**, and * indicate significance at the 1, 5, and
10 percent level. All models include demographic characteristics. Every row entry represents a
different regression on the dependent variable Drinks per Week in year 1. Log Drinks per Week
refers to regressions where the dependent variable is transformed into logs.
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estimates have the same point estimate, but are again insignificant. Among the sample of excessive
female drinkers, I find insignificant estimates across all specifications, but the 2SLS estimates have
economic significance implying a 3 drinks per week increase for quitters. I speculate that gender
specific difference in addiction may contribute to this result. For example, if females are more
heavily addicted to drinking, then quitting smoking may not result in an immediate response in
alcohol consumption. Instead, changes in alcohol consumption may occur more gradually over
time.
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On the other hand, they may suffer from oral-fixation and there increase alcoholic intake.

In summary, I conclude that quitting smoking reduces alcohol consumption by roughly 1.6
drinks or 11% per week among excessive drinkers. Also, quitting smoking reduces alcohol consumption by 2 drinks per week for males and does not statistically affect consumption levels for
females. The results have important policy implications, because individuals consuming alcohol
at excessive levels burden large costs onto society. Therefore, policymakers need to implement
strategies that effectively reduce alcohol consumption to below excessive levels. On average, excessive drinkers consume roughly 14 drinks per week. Subsequently, quitting smoking reduces
alcoholic beverage consumption below the excessive threshold. It also suggests that those people
consume about 6.5 drinks per month less than smokers. These effects can have significant income
effects and health benefits. Among the sub-sample of excessive male drinkers, the reduction of 2
drinks per week translates into a decrease in consumption of 15% per week. Again quitting smoking
will lead on average to an alcoholic beverage consumption below the CDC threshold of excessive
drinking.24

The Impact of Past Cigarette Consumption on Current Alcohol Consumption
The preceding results only investigate the contemporaneous effect of quitting on alcohol consumption without taking the habit stock effect into account. This analysis has three motivations. First,
23

Among the sub-samples, I find statistically significant effects on the extensive margin of drinking in Probit models
by gender, suggesting that smoking reduces the probability of drinking by 6% and 9% for males and females. While
IV-Probit present different insignificant effects.
24
Initial consumption for heavy and binge drinking men prior to the smoking cessation program is roughly 15 drinks
per week.
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the empirical evidence and the rational addiction model suggest that the smoking habit stock affects
current alcohol consumption. Second, the previous section compares the instantaneous relationship
between smoking and drinking, but it can be difficult to understand how one consumption choice
affects another consumption choice immediately. It is possible that a smoking cessation treatment
changes smoking behavior and affects alcohol consumption over time rather than at the same point.
For example, health consciousness and changes towards healthy behaviors are a process that can
be initiated by quitting smoking, but it takes time to change other risky behaviors. Third, relating
past smoking status on current alcohol consumption can be understood as a long-term effect.
I begin by regressing weekly alcoholic beverage consumption on different historic smoking
variables. Specifically, I regress last year’s smoking status on today’s alcohol consumption. However, including a smoking status dummy variable excludes the variation among individuals along
the intensity of historic smoking. A clear feature of the habit effect in the rational addiction model
is that the intensity of smoking conveys information on the level of addiction. Someone smoking in
the past, on average, one cigarette per day should see a different response in alcohol consumption
than someone consuming, on average, 20 cigarettes per day. The availability of monthly cigarette
consumption in all of the last twelve months allows me generate a more comprehensive measure of
the habit stock that affects today’s alcohol consumption. Thus, I utilize all 12 months of smoking
information collected at the first annual follow-up visit to generate a measure of the habit effect.
My preferred specification includes dummy variables for different average levels of past 12
months cigarette consumption.25 This measure differentiates between smoking status as well as
in the intensity of past smoking. For simplification, I generate dummy variable bins in steps of
5 cigarettes s consumed per day in the last year. For example, a participants is in the very low
average smoking bin if the person smoked on average 1-5 cigarettes per day in each month of the
last year. The low smoking bin includes participants with an average cigarettes consumption of
6-10 cigarettes per day in the last year of each month. The heaviest smokers includes highest bin
25

I have also generate a cumulative 12 months cigarette consumption variable. For the cumulative variable I also
included depreciation rates from 0-100% per year. I have also modeled non-linear polynomials relaxing the linearity
assumption of the cumulative smoking measure. In all cases I find similar results
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includes those who consume on average 36 or more cigarettes per day. Such a categorization leads
to an estimation of 8 dummy variables in the regression. I have also used different bin ranges and
draw to similar conclusions. I estimate the average long-term smoking status as the average of the
five annual smoking information. The model for the short-term average smoking level is presented
here:
Drinksit = γ0 +

N
∑

γj Cigsi,j + γXit + µit

(3)

j=1

Where Cigsi,j is a dummy variable equal to one in the jth bin for individual i if his 12 months
average cigarette consumption falls in that bin range and equals zero otherwise. The omitted category includes participants who are non-smokers in the last 12 months.
Endogeneity in the OLS estimates may be one concern that leads to biased estimates. However,
as presented earlier, OLS did not seem to suffer from endogeneity and most of the variation in
the extensive margin of smoking occurs among participants in the treatment group. Additionally,
the changes on the intensive margin of smoking are also very strong among the treatment group
participants with only small reductions in the average consumption of cigarettes among the control
group.26 As a result, the coefficients should not be significantly affected by bias.
Table 6 presents marginal effects for eight dummy variables representing different average
levels of cigarette consumption in the last 12 months in column 1. Columns 2 and 3 present subsample estimates by sex. The estimates follow the theoretical predictions that higher past consumption affects alcohol consumption more strongly. Participants with above average levels of
cigarette consumption consume significantly more alcohol today than those with below average
cigarette consumption levels. Specifically, column 1 shows that participants averaging between
1-5 cigarettes per day do not consume more alcohol than non-smokers. The low consumption of
cigarettes suggests that it may represent “stress” smokers or people who quit smoking for several
months. Someone consuming 6 to 10 cigarettes per day also consumes roughly 1 drink per week
more than non-smokers, a significant increase in alcohol consumption. Estimates also show that
26

The average consumption of cigarettes per day at randomization is 29.5 cigarettes. At the first annual follow-up
visit the average cigarette consumption among the treated is about 12 cigarettes per day and 24 cigarettes among the
control group.
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those consuming on average 31 to 35 cigarettes per day do not consume more than non-smokers.
This finding may be surprising, but may have to do with the fact of the small population in that category (181 observations). Column 2-3 show that the effect of past smoking on alcohol consumption
is larger for females and that past smoking increases alcohol consumption significantly.27
Table 6: The Effect of the 12 Months Average Cigarette
Consumption per Day History on Drinking At the First Follow-up
Meeting
Dep. Var. Drinks per week
Average 12 Months Consumption:
1-5 Cigarettes per Day ≡ 1
6-10 Cigarettes per Day ≡ 1
11-15 Cigarettes per Day ≡ 1
16-20 Cigarettes per Day ≡ 1
21-25 Cigarettes per Day ≡ 1
26-30 Cigarettes per Day ≡ 1
31-35 Cigarettes per Day ≡ 1
36+ Cigarettes per Day ≡ 1
Observations

OLS
Men
Female
0.571
0.420
.923***
(0.353)
(0.516)
(0.313)
0.973***
0.738
1.489***
(0.375)
(0.553)
(0.3253)
1.285*** 1.187** 1.625***
(0.377)
(0.548)
(0.370)
1.184*** 1.137*
1.468***
(0.405)
(0.615)
(0.356)
1.418*** 1.202*
1.955***
(0.462)
(0.676)
(0.440)
1.660*** 1.278** 2.493***
(0.408)
(0.575)
(0.454)
0.754
0.196
1.794***
(0.501)
(0.718)
(0.535)
1.731*** 1.616*** 2.007***
(0.438)
(0 .596)
(.512)
5579
3488
2091

Robust standard errors are in parenthesis. ***,**, and * indicate significance at the 1, 5, and 10 percent level. All models include demographic
characteristics. Each column present results from a single regression. The
Bins variable indicates dummy variables measuring average cigarette consumption in that specific range.
In unreported regressions I also estimate the relationship between a binary smoking variable
measuring smoking status 12 months ago. All estimates are similar in magnitude and are significant at least at the 5% level. Suggesting that not smoking 12 months ago decreases current alcohol
27

As a robustness check I also regressed drinks per week on one continuous average 12 months cigarette per day
consumption variable. The results present significantly smaller effects for the average smoker. Including square and
cube terms of average cigarette consumption generates similar results to those presented in table 6.
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consumption by roughly 1 drink per week or 23%. 2SLS estimates are insignificant, but a Hausman test indicates that OLS estimates are preferred to 2SLS estimates. Probit estimates suggest
that quitting smoking 12 months ago reduces the probability of drinking by 20%, but I find no
statistically significant IV-Probit estimates.28
In summary, the smoking historic influences current alcohol consumption significantly. I find
large heterogeneous effects from the intensity of past smoking decisions on alcohol consumption.
Low levels of smoking tend to have no effect on alcohol consumption, but consuming one pack per
day increases alcohol consumption by about 1.2 drinks per week. Suggesting a significant increase
in overall alcohol consumption of about 28% from the baseline mean. The results, however, have
some caveats., because I only measure an average consumption across the last 12 months. The fact
that some people may quit smoking in some months and relapse in others may misrepresent the
average cigarette consumption per day. Therefore, the next section tries to identify the effect of
those participants who continuously abstain from smoking on alcoholic beverage consumption.

Identifying the Time-Effect of Permanently Quitting Smoking on Alcohol Consumption
Table 6 presents estimates on the effect of 12 months historic average cigarette consumption on
current alcohol consumption. The 12 months average cigarette consumption variable allows for
the possibility that some people change the level of cigarette consumption (or quit smoking) across
month, i.e. they might consume in one month 30 cigarettes and do not smoke in the next month,
which would result in an average consumption of 15 cigarettes per day. Therefore, t this section
tries to understand whether permanently quitting smoking affects alcohol consumption differently.
Additionally, I investigate how the length or timing of quitting smoking affects alcohol consumption.
The addiction theory implies that the level of the habit stock matters as well as the timing of
quitting smoking matters on future alcohol consumption. For example, consider two people with
the same level of the habit stock, where one of the smokers quits smoking and the other continuous
28

Results are not reported, but are available upon request. I ran Linear Probability Models (LPM), and Hausman
tests suggest that OLS estimates can be used over 2SLS estimates.
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smoking. The habit stock of the quitter depreciates over time, while the continuous smoker does
not see a change in the habit stock. As a result, at any future point in time alcohol consumption
of the quitter should be differently affected due to the lower habit stock.29 The following paragraphs explain how I try to measures the timing and the differential habit stock effect on alcohol
consumption.
Specifically, I estimate the timing effect by generating a sample of beginning non-smokers
measured by the months of quitting from the first annual follow-up visit. I specifically exclude
temporary non-smokers (those who relapse in later months). The empirical strategy includes a
dummy variable equal to one if a participant quits smoking permanently. For example, to measure
the effect of 12 months non-smoking on alcohol consumption, the dummy variable equals one if
a person quits smoking 12 months prior to the first annual follow-up visit and does not smoke
in the following 11 months up to the first annual follow-up visit. The dummy variable equals
zero for those participants who are 12 months continuous smokers and part of the control group.
I utilize smokers in the control group as a counterfactual because they have the least differences
in demographic characteristics from the treatment group.30 This gives me a measure of how much
alcohol smokers would have consumed had they not quit. In other words, the counterfactual thought
experiment suggests that what would have happened if the person did not quit smoking for twelve
months, but instead smoked the full year.
The LHS includes self-reported information on smoking for all 12 months prior to the first annual follow-up year, allowing me to run 12 regression between beginning non-smokers in a given
month and alcohol consumption at the first annual follow-up visit. To clarify, each regression,
therefore, includes a different mutually exclusive treatment group from month to month. The treatment group changes from month to month as it only includes beginning sustained non-smokers,
while always including the continuous smokers of the control group. By limiting the sample, I
identify the actual changes in alcohol consumption due to permanent smoking cessation and im29

A detailed explanation of the theoretical background is in the Supplement part 3
The estimation strategy can be thought of as a classical difference in differences model, where quitting smoking
is the exogenous treatment for the smokers.
30
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plicitly measure changes in the habit stock of cigarettes. The regression equation is similar to
equation (1) but includes the here-discussed definition of the smoking variable. For example, for
the 12 month sustained non-smoker the new smoking variable equals one if the following equation
holds, and zero for the continuous smokers in the control group:

N on − Smoker12month = 1, if f

12
[∑

]
smokeim = 0

m=1

N on − Smoker12month = 0, if f

12
[∑

]
smokeim = 12

m=1

Similarly, Smoke11month equals one for smoking in m = 1 and non-smoking in months m =
2, 3, ..., 12, and zero as defined above. To reiterate, each regression only includes one of the 12
generated smoking variables and treatment group is limited to those who smoked in month t − 1
but quit from month t until the first follow-up meeting.
2SLS estimates will identify the effect of sustained non-smokers in the treatment group relative
to continuous smokers in the control group.31 I impose one additional strong assumption to estimate
valid 2SLS models. I assume that the random assignment to the treatment group, which happened
at different times following the third screening survey also results in a random date of receiving
treatment. The first date of possibly receiving treatment would be 12 months prior to the first annual
follow-up visit. Therefore, I assume that those who permanently quit for 12 months are only 12
months non-smokers because they received the treatment earlier in the year than people who quit
smoking for 11 months.
The estimates include a different sample than the estimates presented in Table 6. The interpretation of quitting smoking in month 12 suggests that the participant did not smoke in all of the
following months up to the first annual follow-up visit. The previous section did not make any restrictions on month-to-month smoking habits. To distinguish the results from the previous section
I refer to a smoker quitting in month 12 who remain a non-smoker in all of the following months
31

Non-parametric estimation strategy should yield similar results, where I could compare the difference in alcohol
consumption between permanent quitters in the treatment group relative to continuous smokers in the control.
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as a “12 month sustained non-smoker”. The sample of sustained non-smokers may be different
from the overall sample and suffer from sample selection. I tested for differences in any of the five
observable characteristics (gender, education level, marital status, age, and cigarette consumption
at baseline) for the 12-8 months sustained non-smoker from the control group participants. I only
find a statistically significant difference in marital status for 12, 10 and 9 months sustained quitters
and gender for 12 months sustained quitters. In total I conducted 20 tests and had to reject in 5 cases
and only once at the 1% level. I conclude that there may be some evidence for possible differences
by marital status between treatment and control group.
Figure 1 graphs the OLS and 2SLS marginal effects on the effect of becoming a sustained nonsmokers for 12 to 8 months on alcohol consumption.32 I find statistically significant results for 12
months sustained non-smokers. 2SLS results indicate that 12 months sustained non-smokers consume 1.2 drinks per week or 27.5% less than continuous smokers. 11 through 9 months sustained
non-smokers consume about 0.6 drinks more per week than a 12 month sustained non-smoker.
Nevertheless, sustained quitters beginning in month 11 through 9 consume 0.6 drinks, or 14%, less
that continuous smokers.33 Overall, the marginal effects follow the expected inverse relationship
between quitting smoking and alcohol consumption. Quitting smoking later in the year and closer
to the first annual follow-up visit results in a higher habit stock of smoking, which increases alcohol
consumption.
Similarly, I also find large extensive margin effects of quitting smoking permanently on drinking. Table 7 includes average marginal effects for probit, and CF-probit estimates. 12 months
sustained non-smokers are 31% less likely to drink than continuous smokers. 11 months sustained
non-smokers are roughly 5% less likely to drink than continuous smokers.34 The extensive margin
effects follow the results from Figure 1. The longer one permanently abstains from smoking the
32
I present only months 12 through 8, because limiting the sample has its cost on observations and power. Beginning
in month 7 and any later month sustained quitters represent only a small fraction of the sample, questioning any internal
validity. For example, in June only 36 people become sustained quitters for the rest of the year. Beginning in August,
the average month sees 11 sustained quitters. Therefore, I am not confident that the estimates from month 7 and onward
represent representative average effects.
33
Appendix Table A.2& A.3 present regression and Negative Binomial marginal effects.
34
Logit results presents similar average marginal effects. Table not included.
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Figure 1: Average Alcoholic Beverage Consumption for Beginning Sustained Non-Smokers
in Different Months Prior to the First Annual Follow-up Visit

Figure 1 plots OLS and 2SLS marginal effects from Table A.2. Results present the
effect of becoming a sustained non-smoker in months 12,11,10... prior to the first
annual follow-up visit on alcohol consumption.

larger the effects on alcohol consumption.
Taking all results, I conclude that the length of quitting smoking affects alcohol consumption
differently. Moreover, since the average cigarette consumption as baseline for those who permanently quit 12 months is about 30 cigarettes per day, I conclude that the estimates are similar
compared to Table 6, and therefore providing evidence that the effect is robust to specification.35
Additionally, the theoretical model supports the prediction that a longer period of abstaining from
smoking decreases the habit stock through depreciation and results in a larger drop in alcohol consumption. Next, I present results by gender, as Pierani et al. (2009) also suggest that those differ.

Gender Differences on the Effect of the Habit Stock on Alcohol Consumption
Pierani et al. (2009) present significantly different results for the habit stock by gender. This
section estimates the gender difference in the effect of permanently quitting smoking on alcohol
consumption. Table 8 presents OLS and 2SLS estimates for all beginning sustained non-smokers
35

On average a 12 through 8 months sustained quitter consumed close to 30 cigarettes per day which leads to very
similar point estimate for the 12 month sustained quitter.
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Table 7: The Effect of the Length of Abstaining from
Smoking on the Probability of Drinking at the First
Annual Follow-Up Visit
Dep. Var. Any Drinks
Length of Non-Smoking
12 Months Sustained Non-Smoker

Probit
-0.39***
(0.02)
11 Months Sustained Non-Smoker -0.04***
(0.03)
10 Months Sustained Non-Smoker
-0.01
(0.026)
9 Months Sustained Non-Smoker
-0.016
(0.03)
8 Months Sustained Non-Smoker
-0.004
(0.04)
7 Months Sustained Non-Smoker
-0.003
(0.06)
6 Months Sustained Non-Smoker
-0.021
(0.08)
5 Months Sustained Non-Smoker
-0.10
(0.08)
4 Months Sustained Non-Smoker
-0.021
(0.09)
3 Months Sustained Non-Smoker
0.057
(0.09)
2 Months Sustained Non-Smoker
0.017
(0.09)
1 Month Sustained Non-Smoker
0.04
(0.08)

CF-Probit
-0.31***
(0.03)
-0.05
(0.03)
-0.01
(0.03)
-0.02
(0.027)
-0.001
(0.04)
-0.026
(0.08)
-0.099
(0.10)
-0.021
(0.12)
-0.10
(0.12)
-0.30
(0.01)
-0.12
(0.14)
-0.03
(0.13)

Robust standard errors are in parenthesis. ***,**, and * indicate significance at the 1, 5, and 10 percent level. Column 1
presents Probit estimates between a binary drinking indicator,
equal to one if the person quit smoking continuously beginning that months and zero otherwise, and alcoholic beverage
consumption per week. All estimates present average marginal
effects.
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beginning in month 12 through 1 before the first follow-up visit. Figure 2 graphs 2SLS marginal
effects by gender for months 12 to 8 beginning sustained non-smokers. The figure shows that the
shorter the period of abstaining from smoking the higher the alcohol consumption. Across the
length of quitting the trend for females are more linear than males. However, among the male
sub-sample I only find statistically significant OLS results for 12 months non-smoking. I find
statistically significant OLS and 2SLS marginal effects for 12 and 11 months female sustained
non-smokers. Specifically, I find that female 12 month sustained non-smokers consume 1.8 drinks
per week less, while 12 months male non-smokers consume 1 drink per week less than continuous
smokers.
Figure 2: Effects of Becoming a Sustained Non-Smokers on Alcohol Consumption by
Gender

Figure 3 presents 2SLS marginal effects for Table 8. Results present the effect of
becoming a sustained non-smoker in months 12,11,10... prior to the first annual
follow-up visit on alcohol consumption.

Similarly, I also estimate probit and CF-profit models by gender. Table 9 presents probit, and
CF-probit average marginal effects. I find that 12 months sustained male and female non-smokers
are 30% and 32% less likely to drink, respectively. Both estimates are statistically significant at
the 1% level. Additionally, 11 months female sustained non-smokers are roughly 10% less likely
to drink than continuous female smokers. Interestingly, women are slightly more likely to quit
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Table 8: The Effect of the Length of Abstaining from Smoking on Alcohol
Consumption at the First Annual-Follow-up Visit
Female
Length of Non-Smoking
12 Months Sustained Non-Smoker
11 Months Sustained Non-Smoker
10 Months Sustained Non-Smoker
9 Months Sustained Non-Smoker
8 Months Sustained Non-Smoker
7 Months Sustained Non-Smoker
6 Months Sustained Non-Smoker
5 Months Sustained Non-Smoker
4 Months Sustained Non-Smoker
3 Months Sustained Non-Smoker
2 Months Sustained Non-Smoker
1 Month Sustained Non-Smoker

OLS
-1.744***
(0.365)
-1.014*
(0.540)
-0.422
(0.445)
-0.215
(0.485)
-0.040
(0.713)
0.572
(1.838)
-1.408
(0.937)
-0.947
(1.073)
0.033
(1.272)
-0.071
(1.272)
-2.158***
(0.362)
-1.417
(0.929)

Male

2SLS
OLS
2SLS
-1.791***
-1.111*
-0.986
(0.379)
(.596)
(0.633)
-1.096**
-0.445
-0.527
(0.548)
(0.618)
(0.620)
-0.583
-0.750
-0.647
(0.449)
(0.500)
(0.509)
-0.328
-0.891*
-0.893*
(0.511)
(0.496)
(0.502)
-0.230
-0.428
-0.099
(0.736)
(0.735)
(0.789)
-2.377
-1.144
-1.915**
(0.677)
(1.084)
(0.823)
-0.701
0.254
-0.993
(1.486)
(1.392)
(1.584)
2.917***
1.149
1.959
(0.399)
(1.940)
(2.488)
0.460
-0.009
-0.464
(2.177)
(1.717)
(1.671)
-0.444
-3.284***
-1.033
(2.179)
(1.006)
(1.233)
2.551***
-1.678
-3.185***
(0.418)
(1.240)
(1.087)
-1.249
0.811
0.869
(1.414)
(1.223)
(1.802)

Robust standard errors are in parenthesis. ***,**, and * indicate significance at the 1, 5,
and 10 percent level. All models include demographic characteristics. Every row entry
represents a different regression and different sample on the dependent variable Drinks per
Week in year 1. Table 8 presents OLS and 2SLS marginal effects for a binary indicator
equal to one for a beginning non-smoker for the rest of the year and zero for a continuous
smoker.
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drinking than men. This is counterintuitive to the current evidence that women tend to become
addicted more easily and should have a more difficult time quitting abruptly.
Finally, the evidence shows that women reduce alcoholic beverage consumption and are more
likely to quit drinking if they become a sustained non-smoker for 12 or 11 months. 12 month
non-smoking females reduces alcohol consumption by 53% per week and 11 months non-smoking
females reduce alcohol consumption by 29% relative to baseline consumption levels at the randomization meeting. Among men, those who become sustained non-smokers for 12 months decrease
alcohol consumption by 23%. The evidence suggests that the length of quitting affects alcohol
consumption significantly. Moreover, I present evidence that implies that the habit stock affects
females more than males, because the change in alcoholic beverage consumption among females
is twice as large as the change for males. In a different light, the estimates suggest that there are
long-term benefits from quitting smoking via a reduction in alcoholic beverage consumption.
Table 9: Sub-sample Gender Effects of the Length of Abstaining from Smoking
on the Probability of Drinking Any Alcoholic Beverages at the First Annual
Follow-up Visit
Female
Length of Non-Smoking
12 Months Sustained Non-Smoker
11 Months Sustained Non-Smoker
10 Months Sustained Non-Smoker
9 Months Sustained Non-Smoker
8 Months Sustained Non-Smoker

Probit
-0.37***
(0.04)
-0.10*
(0.054)
-0.02
(0.04)
0.01
(0.04)
0.05
(0.07)

Male

CF-Probit
Probit
-0.32*** -0.40***
(0.05)
(.03)
-0.12*
-0.01
(0.06)
(0.03)
-0.03
-0.006
(0.005)
(0.03)
0.01
0.01
(0.05)
(0.03)
0.05
-0.03
(0.07)
(0.04)

CF-Probit
-0.30***
(0.03)
-0.01
(0.04)
-0.01
(0.03)
0.02
(0.034)
-0.02
(0.05)

Robust standard errors are in parenthesis. ***,**, and * indicate significance at the 1, 5,
and 10 percent level. Table 8 presents average Probit marginal effects and Probit Control
Function Approach marginal effects for a binary variable equal to one if the person is a
beginning sustained non-smoker for the rest of the year and zero for a continuous smoker.
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The Effect of Quitting Smoking on Alcohol Consumption after Five Years
All previous results present short-term average effects on the effect of smoking on alcohol consumption. This section estimates the long-term effects and compares them with the short-term
effects. It is possible that people who quit smoking abruptly decrease alcohol consumption by the
first follow-up visit, but increase consumption in the long-term. To this end, I present OLS and
2SLS long-run estimates for two different smoking variables on alcohol consumption by the 5th
annual follow-up visit. I present long-term effects for the objectively-verified smoking variable
and the 12 months sustained quitters variable from the previous sections.
Table 10: Long-Run Effects of Quitting Smoking
Objective Smoking Status:

Short-Run

OLS
Smoking status at first follow-up visit 0.447**
(0.185)
12 months sustained non-smokers
-1.251***
(0.403)

2SLS
0.482
(0.741)
-1.183***
(0.428)

Long-Run
OLS
0.497**
(0.195)
-1.112***
(0.401)

2SLS
0.542
(0.771)
-1.115***
(0.422)

Robust standard errors are in parenthesis. ***,**, and * indicate significance at the 1, 5,
and 10 percent level. All models include demographic characteristics. Every row entry
represents a different regression on the dependent variable Drinks per Week in year 1 for the
Short-Run and year 5 for the Long-Run.
Table 10 presents the main results and shows no significant changes in coefficient size after five
years. I test for differences between the short-run OLS and long-run OLS coefficients but do not
find statistically significant differences.36 The key take away is that the short-run effect of lower
alcohol consumption persists after five years.

Conclusion
This paper presents strong evidence that smoking and alcoholic beverage consumption is positively
correlated. On average, quitting smoking reduces alcohol consumption by roughly 0.5 drinks per
week or 11.5%. Among excessive alcohol users, quitting smoking reduces alcohol consumption
36

A Table presenting those results can be made available upon request.
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by about 1.7 drinks or 15% per week. The estimates also reveal heterogeneous smoking habit
stock effects on alcohol consumption. I show that participants consuming on average between
1-5 cigarettes per day in the last 12 months prior to the first annual follow-up meeting do not
increase current alcohol consumption relative to non-smokers. However, consuming on average 20
cigarettes per day increases current alcohol consumption by 1.2 drinks per week. . Additionally,
I show that the longer the participant abstains from smoking the stronger the negative effect on
alcohol consumption
The study suggests that smoking interventions present a powerful policy approach that minimize cigarette and alcohol demand. Smoking interventions have a dynamic second-order effect
on alcohol demand, suggesting that policymakers could have underestimated the total benefits of
smoking interventions. I hypothesize that the second-order effects from a smoking intervention
can also be partially achieved in the general smoking population, if they are combined with an
effective nicotine prescription program. However, the consistently shrinking smoking population
lessens the total second order benefits, requiring broader actions targeting non-smoking drinkers.
A separate literature points out that quitting smoking increases BMI, but the mechanisms are
still debated.37 Alcoholic beverage consumption significantly increases caloric and could be one
mechanism through which recent quitters compensate or ameliorate the painful detoxification process to stay away from cigarettes. This paper provides evidence that quitters do not substitute their
physical and psychological cigarette dependence by increasing alcoholic beverage consumption.
To the contrary, especially for sustained non-smokers, those who stop smoking tend to drink less
alcoholic beverages, cutting additional calories out of their diet.
Lastly, a back of the envelope calculation estimating the costs savings from the intervention
that would otherwise have occurred due to excessive alcohol consumption suggests annual saving
of about 645,000 dollars.38 The recent passage of the Affordable Care Act also requires insurers to
cover smoking cessation treatment costs of the insured and could generate cost savings similar as
37

See Courtemanche 2009, Chou et al. 2004.
918 LHS participants were classified as continuous non-smokers by the 5th year. 129 were classified as excessive
drinkers at the baseline meeting. Based on Sack et al. 2015 a conservative estimate suggests that the cost of excessive
drinking per excessive drinker is at 5000 dollars.
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the LHS per person. For example, taking current estimates from Sachs et al. (2015), a 1 percentage
point drop in smoking participation can save around 300 million dollars annually that would have
otherwise been incurred from excessive drinking.39

II

The Effect of Smoking on Obesity: Evidence from a Randomized Trial

Introduction
In the last 40 years obesity40 rates have steadily increased in the United States (US), rising from 13%
in the early 1960s to 35% in 2011-2012 (Flegal et al., 1998, Ogden et al., 2014). This rise in obesity
has contributed significantly to increasing rates of diabetes, heart disease, and stroke (Mokdad et
al. 2001, Manson et al. 1990, Rexrode et al. 1997), with Flegal et al. (2005) finding that obesityrelated diseases lead to 112,000 deaths per year. Wang et al. (2011) project that by 2030 the number
of obese adults in the US will grow by another 65 million. Cawley and Meyerhoefer (2012) estimate
that obesity leads to $190 billion per year in medical expenses, while Wang et al. (2011) project
that this number will increase by $48 to $66 billion by 2030.
During the same time frame, the percentage of adults who use tobacco in the US declined from
42% to 19% (National Center for Health Statistics, 2011). The 1964 Surgeon General’s Report
concluded that smoking leads to adverse health conditions such as lung cancer and heart disease
and increases mortality risk (US Department of Health and Human Services, 1964). Subsequently,
federal and state governments launched an aggressive tobacco control campaign featuring advertising restrictions, warning labels, information-spreading programs, cigarette taxes, and smoking
bans in public places. Despite the success of these efforts in reducing smoking, tobacco is still
responsible for one out of every five deaths in the United States and at least $130 billion per year
39

CDC and the LHS suggest that 15 percent of smokers consume at excessive alcohol levels
Obesity is defined as having a body mass index (BMI) greater than 30, where BMI is equal to weight in kilograms
divided by height in meters squared.
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in medical expenses (US Department of Health and Human Services, 2014).
The inverse trends in smoking and obesity raise the question of whether they are causally related, in which case tobacco control policies may had the unintended consequence of contributing
to the rise in obesity. Quitting or reducing smoking could increase body weight since nicotine can
act as an appetite suppressant and metabolic stimulant (Pinkowish, 1999). In standard economic
models of body weight (e.g. Philipson and Posner, 1999), nicotine’s appetite-suppressing properties could be seen as decreasing the marginal utility of food consumption, leading to less eating and
therefore lower body weight. Stimulating the metabolism would mean more calories burned holding physical activity constant, again reducing weight. On the other hand, smoking reduces lung
capacity (Hedenstrom et al., 1986), which could lead to weight gain by increasing the marginal
disutility from exercise.
A large public health literature documents that individuals tend to gain weight following smoking cessation. A meta-analysis of 15 studies found that individuals who quit smoking gain an
average of four pounds more than a comparison group of continued smokers (U.S. Department of
Health and Human Services, 1990). Another meta-analysis, which included a larger number of
studies (62) but no comparison group, found that weight gain steadily increases in the year after
smoking cessation, ultimately reaching 4.67 kg (10.3 lbs) (Aubin et al., 2012). Evidence regarding
longer-run effects is mixed. Some studies have found that much of the weight gain after quitting
smoking is temporary (Chen et al., 1993; Mizoue et al., 1998), but others conclude that the effect remains sizeable five to ten years after cessation (Flegal et al., 1995; Travier et al., 2012; Williamson
et al., 1991). These associational estimates could be susceptible to bias from unobservable characteristics, such as time preference and level of interest in one’s health, that likely influence both
the probability of smoking cessation and weight trajectory. Additionally, studies that simply track
changes in weight without utilizing a comparison group of continued smokers are susceptible to
additional confounding from the tendency to gain weight with age.
The economics literature has attempted to move closer toward causality by examining the effects of plausibly exogenous sources of variation in economic factors that influence smoking on
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BMI. The results from this literature are mixed. Chou et al. (2004), Rashad et al. (2006), and Baum
(2009) estimate positive relationships between cigarette costs and BMI. Since higher cigarette
prices have been shown to reduce smoking, these results are consistent with reduced smoking leading to weight gain. However, Gruber and Frakes (2006), Courtemanche (2009), and Wehby and
Courtemanche (2012) estimate the effect of cigarette costs on BMI to actually be negative, while
Nonnemaker et al. (2009) and Courtemanche et al. (forthcoming) find little evidence of an effect
in either direction. The discrepancies in observed results in the literature hinge on methodological issues such as whether cigarette prices or tax rates are used as the measure of cigarette costs,
whether time is modeled using a quadratic trend or time period dummies, and whether the difference between short-run and long-run effects is considered. A particularly controversial issue
is whether cigarette costs can actually be considered exogenous. Cigarette prices may depend on
the demand for cigarettes, while high cigarette taxes may be more politically palatable in states
where a relatively small percentage of the population smokes. Fletcher (2014) considers a different tobacco-control policy – workplace smoking bans – and finds evidence that smoking cessation
induced by these bans increases BMI.
To our knowledge, the only paper that uses a randomized intervention to estimate the causal
effect of smoking on weight is Eisenberg and Quinn (2006; hereafter EQ). EQ use the Lung Health
Study (LHS), which randomly assigned smokers to a comprehensive smoking cessation program
and then tracked their health for five years. EQ do not actually use the LHS microdata, but instead
take advantage of the fact that O’Hara et al. (1998) report differences between the treatment and
control groups’ average changes in weight and smoking status to compute a Wald instrumental
variables (IV) estimate of the weight gain from quitting smoking. EQ find that quitting smoking
leads to a very large average weight gain of 9.7 kg (21.4 pounds), about two to five times the
magnitude typically found in the associational literature.
Despite their use of randomization, there are reasons to suspect that EQ’s estimate is overstated.
They use assignment into the smoking cessation program as an instrument for ”sustained quitting”,
which is defined as being a medically verified quitter in all five LHS follow-up waves. The IV
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strategy therefore requires the strong assumption that the program only affects weight through its
effect on sustained quitting. However, in addition to helping some smokers quit immediately and
permanently, the program may help others quit smoking in some but not all follow-up periods,
and still others by reducing their number of cigarettes smoked per day even though they never quit
entirely. To the extent that such partial quitting exists and influences BMI, EQ’s estimated average
effect of quitting smoking will be biased upwards.
We contribute to the literature on the effect of smoking on weight in several ways. First, we
provide, in our view, the most reliable estimates to date of the average causal effect of quitting
smoking on weight. We use the LHS microdata to exploit the randomized nature of the study
while also constructing detailed smoking measures – such as cigarettes smoked per day and average
carbon monoxide (CO) level over the entire five-year period of the study – that account for delayed
or temporary quitting as well as smoking intensity. Our preferred estimates imply that quitting
smoking leads to an average weight gain of 1.5-1.7 BMI units (10-11 pounds at the average height)
at the end of the first year of the study period. The effect persists over time, reaching 1.7-1.9 BMI
units (11-12 pounds) by the end of the fifth year – a magnitude that implies that the fall in smoking
explains around 14% of the rise in BMI in recent decades. Our estimated effects are toward the
high end of the range of results from the associational literature, but substantially smaller than EQ’s
estimate that uses randomization but relies on the ”sustained quitting” measure.
Our paper also contributes by providing new information related to the heterogeneity of the effect across the smoking and weight distributions as well as by demographic characteristics. We
estimate a semi-parametric instrumental variables model that allows the data to determine the
functional form of the relationship between smoking and BMI. The results suggest a diminishing marginal effect, with additional smoking having little long-run impact on BMI beyond about
a pack of cigarettes per day or a CO level of about 20 parts per million (ppm). We also conduct
subsample analyses by age, gender, education, and baseline BMI and find that on average younger
individuals, females, those with no college degree, and those with healthy baseline BMI levels gain
the most weight in response to smoking cessation.
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Data
This section provides a brief introduction to the LHS, with an emphasis on the information most
relevant for our paper. O’Hara et al. (1993, 1998) provide a more detailed discussion of the LHS,
and further information is also available online at https://www.clinicaltrials.gov.
The purpose of the LHS was to observe changes in the severity of chronic obstructive pulmonary disease (COPD) among smokers. The study consisted of 5887 smokers with initial ages
between 35 and 59. Recruitment started in 1986 and ended in 1989. The clinical trial ended in
1994. To be eligible for selection, potential participants had to show signs of mild lung function
impairment, have no history of certain medications, consume less than 25 drinks per week, and
have no severe illnesses or chronic medical conditions. Each year all participants were extensively
interviewed individually at a medical clinic near the residence of the participant (no more than 75
miles away from the participant’s permanent residence). The data therefore consist of the baseline
period (1989) plus five annual follow-up periods (1990 through 1994). Attrition was relatively
low, as 5,297 individuals remained in the sample in the final wave. The attriters included 315
participants who died during the study period.
Participants were randomly assigned into three different groups: two treatment groups and one
control group. Both treatment groups received a special intervention (SI) consisting of free nicotine
gum, an intensive quit week, and frequent contact with support personnel with invitations to bring
a spouse or relative to the meetings. The only difference between the two treatment groups is that,
in addition to the SI, one group received an inhaled bronchodilator (SI-A) while the other received
an inhaled placebo (SI-P). Most of the intensive intervention treatments were completed within the
first 4 months of the study. The control group referred to as the usual care (UC) group received no
intervention and members continued to use their own private sources for medical care.
The LHS collected information about weight, height, smoking behavior, family smoking habits,
health status, and demographic characteristics. Weight and height were measured by medical staff
at the participants’ clinic visits, so our BMI measure is not susceptible to the concern about measure-
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Table 11: Summary Statistics
(Means, with Standard Deviations in Parentheses)
Variable
SI-A
SI-P
UC
Age
48.41
48.55
48.43
(6.84)
(6.83)
(6.80)
Cigarettes per Day
29.59
29.49
29.53
(14.08) (13.60) (14.11)
Carbon Monoxide
25.97
26.70
25.98
(13.47) (12.67) (12.66)
BMI
25.42
25.67
25.55
(3.91)
(3.92)
(3.92)
High School Degree
0.29
0.30
0.29
(0.45)
(0.46)
(0.45)
Some College
0.34
0.34
0.35
(0.47) (0.47)
(0.47)
College Degree
0.22
0.22
0.24
(0.41) (0.42)
(0.42)
Male
0.60
0.64
0.64
(0.49) (0.48)
(0.48)
Married
0.65
0.67
0.65
(0.47) (0.47)
(0.47)
Observations
1961
1962
1964
ment error that is common in the economics of obesity literature.41 The data contain self-reported
smoking information as well as CO test results. We consider three different measures of smoking:
a dummy variable for whether the respondent currently smokes (clinically measured through the
CO test), number of cigarettes typically smoked per day (self reported), and CO level in ppm. We
also utilize the LHS’ information on education (dummies for high school graduate, some college,
and college graduate), gender (dummy for male), age (years), and marital status (dummy for married) as controls. Note that we do not control for race/ethnicity because 97% of LHS participants
were white. Our sample is therefore not representative of the overall population of US smokers
along this dimension.
Table 11 presents descriptive statistics for the three groups at the time of randomization. Average cigarette consumption was roughly 30 cigarettes per day, average CO level was about 26, and
41

See Courtemanche et al. (2015) for an overview of the challenges involved with using self-reported weight and
height.
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the average respondent was just slightly overweight. The summary statistics for all variables are
very similar across the three groups, indicating the randomization was successful.

Cigarettes per Day
10 15 20 25 30

Percent Smoking in Sample
.6 .7 .8 .9 1

Figure 3: Changes Over Time in BMI and Smoking for Treatment and Control Groups
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Figure 3 displays changes throughout the sample period in the average number of cigarettes
smoked per day, objectively-verified smoking status, CO level, and BMI for each group. Sharp
decreases in cigarette smoking, smoking status and CO level are evident for both treatment groups
in the first year after the intervention. The decrease in smoking for the control group is much more
moderate. Average BMI is trending upward for all three groups, but the two treatment groups
experience much sharper increases in BMI than the control group in the first year. The graph
therefore suggests both that the intervention was effective in reducing smoking and that smoking
reduces BMI. We next use econometric methods to estimate the magnitude of these effects.
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Econometric Analyses
Our econometric objectives are to identify 1) the average short- and long-run causal effects of quitting smoking on weight gain, 2) how the effect of smoking on weight changes across the smoking
distribution, and 3) how the effect of smoking on weight varies by demographic characteristics and
baseline BMI. We begin by using parametric regressions to answer the fist question and running falsification tests to evaluate the validity of the models. We then conduct semiparametric estimation
allowing for a flexible relationship between smoking and weight to address the second question.
Next, we answer the third question with subsample analyses. Finally, we address issues related to
the generalizability of the results and show why our results differ from those of EQ.

Average Effects
Short Run
We begin by aiming to identify the average causal effect of quitting smoking on weight gain with a
series of parametric regressions. Economists typically consider body weight to be a capital stock.
Individuals start with an exogenous endowment of weight that changes over time due to depreciation as well as “investments” that take the form of caloric intake or expenditure. In the LHS, weight
at the end of the first follow-up year can therefore be modeled as a function of weight at baseline
and investments – such as smoking – in year one. This leads to the model

bmii1 = β0 + β1 bmii0 + β2 Si1 + β3t Xi + εi1

(4)

where bmii1 is individual i’s BMI at the end of year 1, bmii0 is BMI at the beginning of the study
(year 0), Si1 is smoking in year 1, Xi is a vector of demographic controls that are assumed to be
constant over time since they are only available for the baseline wave, and εi1 is period 1’s error
term. β2 , the coefficient of interest, gives the short-run association between smoking and weight.
We estimate the OLS model given by (4) as well as an IV model that uses the randomized treatment
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assignment to instrument for Si . The first stage of the IV model is given by

Si1 = γ0 + γ1 wi0 + γ2 si_ai + γ3 si_pi + γ4 Xi + µi1

(5)

where si_ai and si_pi reflect whether the individual was assigned into the SI-A or SI-P treatment
group, respectively. The second stage of the IV model is identical to (4) except it replaces Si1
with the predicted value generated by (5). In the IV model, β2 can be interpreted as the short-run
local average treatment effect (LATE) of intervention-induced changes in smoking on BMI. We
estimate linear models in both stages due to their relative ease of interpretation, their ability to
produce reliable average effects (e.g. Angrist and Pischke, 2009), and the inherent difficulties with
non-linear IV estimation (e.g. Terza et al., 2008). We define Si1 three different ways: a dummy
for smoking cessation, number of cigarettes smoked per day, and CO level. We next discuss these
three smoking variables.
The first smoking measure is a dummy equal to one if and only if individual i was a medically
validated non-smoker at the end of year one. We consider this to be a naive measure of smoking because it ignores variation in smoking intensity among smokers. This could lead to an overstatement
of the average weight gain from quitting smoking estimated by IV models. When a quit dummy is
used as the smoking measure, the IV estimator effectively scales the difference in BMI between the
treatment and control groups by the difference in smoking cessation rates between the two groups.
The validity of this estimator therefore hinges on the assumption that the randomized intervention
only affected the BMIs of people who fully quit smoking. To the extent that the intervention also
affected the BMIs of those who cut back on smoking but did not quit entirely, the difference in
BMI will be scaled by too small a number and the resulting IV estimate will be too large. (This
point is central to our critique of EQ, and we will discuss it in more detail in Section 3.5.)
Our second smoking measure is therefore self-reported number of cigarettes smoked per day,
with a value of zero assigned to those who reported quitting. This measure incorporates both reducing smoking and quitting entirely and therefore is not susceptible to the above criticism. In
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order to make the results using cigarettes per day comparable to βb2 from the regressions using
the smoking cessation dummy, we need to compute an implied average weight gain from quitting
smoking. Since the best way to do this is not immediately obvious, we consider several possibilities. First, we use the average weight that would be gained if all individuals in the sample switch
from their baseline number of cigarettes to none. We do this by multiplying the coefficient estimate on the cigarettes smoked per day variable by each individual’s number of cigarettes smoked
at baseline, and then taking the average across all individuals. Formally, this means we compute
)
(N
∑
β2 cigdayi0 /N , where cigday is cigarettes smoked per day and i indexes the N observai=1

tions. Second, we use the same formula but average over only those individuals who actually quit
smoking. Third, we only average over quitters from the treatment groups. Fourth, we compute the
effect of quitting smoking from the sample mean baseline smoking level, i.e. β2 cigday i0 . Fifth
and sixth, we again compute β2 cigday i0 but using only quitters, and quitters from the treatment
group, respectively. The estimated average weight gain from quitting smoking is similar using all
six approaches, so we only report the results using the first method: averaging the predicted effects
across all individuals. Results from the other approaches are available upon request.
A key limitation with cigarettes per day is its self-reported nature. At issue for the validity
of our IV estimates is not whether cigarettes per day are reported with error, but whether this
error is correlated with treatment status. It is not obvious that this is the case, but it is possible
that, for instance, being assigned into the treatment group creates more pressure to report progress
toward smoking cessation, leading to differentially large reporting error among the treatment group.
Alternatively, perhaps reporting error simply rises with number of cigarettes smoked per day, in
which case we would expect the amount of error in the follow-up periods to be highest among the
control group.
We therefore also utilize a third smoking variable that is both clinically measured and incorporates both the intensive and extensive margins of smoking: CO level from a test conducted during
the follow-up interview. Using the CO regression estimates to compute the average weight gain
from quitting smoking is somewhat more complicated than using cigarettes smoked per day since
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even non-smokers generally have a positive CO level. We therefore compute each individual’s predicted effect of quitting smoking as the effect of switching from her baseline CO level to the mean
CO level for non-smokers, rather than to a CO level of zero. For the mean CO level of non-smokers,
we use Deveci et al.’s (2004) estimate of 3.61 ppm; this is similar to the mean CO level of verified
non-smokers in the follow-up waves of the LHS. The average effect of quitting smoking on weight
(N
)
∑
across the entire sample is therefore given by
β2 (COi0 − 3.61) /N where CO is CO level in
i=1

ppm. Note that CO levels are only available at baseline for 922 individuals, so our average effect
is computed using only this portion of the sample (though our regressions still utilize the full sample). We doubt that this limitation is of consequence since reported numbers of cigarettes smoked
per day at baseline are virtually identical for those with missing baseline CO levels and those with
non-missing levels. We have also considered analogs of the other five approaches to computing
the average effects of quitting smoking discussed above and verified that, as with cigarettes per
day, the results are robust.
While using CO levels solves the probability of reporting error, it should be noted that it is
not immune to all sources of measurement error. In particular, it only reflects smoking in the
past couple of days. Therefore, for some people self-reported number of cigarettes smoked per
day could actually be more indicative of typical smoking behavior than clinically measured CO.
Consequently, we take an agnostic view about which measure is preferred and present the results
for both alongside each other throughout the paper.42

Long Run
The above specifications estimate the short-run causal effect of smoking on BMI. We also aim to
identify the long-run effect by asking how smoking across all five follow-up waves affects BMI at
the end of the study (year five). Comparing the short- and long-run effects is important since, as
42

If we regress CO level in the first follow-up year on cigarettes smoked per day as well as the interaction of cigarettes
with the two treatment dummies, the R-squared is 0.48. This suggests that, while cigarettes smoked per day and CO
are highly correlated, they do convey different information. Additionally, the coefficients on the interaction terms are
positive and significant, though small. In other words, measurement error does appear to be slightly correlated with
treatment status. Both of these results underscore the importance of verifying that the results are similar using the two
different measures.
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discussed in Section 1, the evidence from the associational literature is mixed as to whether at least
some of the weight gained after quitting smoking is temporary. Ideally, we would like to estimate

bmii5 = β0 + β1 bmii0 +

5
∑

β2t Sit + β3 Xi + εi5

(6)

t=1

where bmii5 is individual i’s BMI at the end of year 5 and Sit is smoking in year t. However, the
need to utilize IV estimation prevents us from allowing separate coefficients for each of the five
smoking variables, as this would require five instruments. In other words, in order to operationalize
an IV model we need to compress the five years of smoking information into a single variable Si .
The easiest way to do this is to take a simple average across the five years:

Si =

Si1 + Si2 + Si3 + Si4 + Si5
.
5

(7)

However, this approach assumes that smoking in each of the five periods has the same effect
on weight. To the extent that weight is a depreciating capital stock, we might expect smoking in
more recent years to have a larger effect on BMI than smoking in more distant years. We therefore
also estimate models defining S as a weighted rather than simple average of quit status in the five
follow-up years:

Si =

Si1 + (1 − δ)Si2 + (1 − δ)2 Si3 + (1 − δ)3 Si4 + (1 − δ)4 Si5
.
1 + (1 − δ) + (1 − δ)2 + (1 − δ)3 + (1 − δ)4

(8)

Since we do not have a sufficient number of instruments to credibly estimate the depreciation rate
δ, we simply try several plausible values: 0.05, 0.1, 0.15, 0.2, 0.25, and 0.3. In all our regressions,
the coefficient estimate on the baseline BMI variable will barely be below one, so we consider it
probable that the “true” value of δ is toward the low end of this range; i.e. there is little reason to
consider values of δ above 0.3.
We estimate equation (6) using both OLS and IV, with si_ai and si_pi again serving as the instruments. We again use the three different measures of Sit : smoking cessation, cigarettes smoked
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per day, and CO level. For the cigarettes per day and CO regressions, we compute implied average
effects of quitting smoking in the same manner as the short-run specifications.

Results
Table 12 reports the results of interest from the parametric regressions. Panel A presents the OLS
and IV estimates of the effects of the different smoking measures on BMI. Panel B shows the
estimated effects of the treatment dummies on the smoking variables from the first stage of the IV
models, along with the F-statistic from a test of their joint significance. The first three columns
show the effect of year 1 smoking on year 1 BMI (short-run effect), with the first column using
the binary quitting variable as the smoking measure, the second using cigarettes smoked per day,
and the third using CO. The last three columns present the effects of the simple averages of these
three smoking measures across years 1-5 on BMI in year 5 (long-run effect). The results using
the weighted averages, available in Appendix Table A1, are similar to those obtained using simple
averages.
Coefficient estimates are shown in the table, with heteroskedasticity-robust standard errors in
parentheses. The stars represent 0.1%, 1%, and 5% significance levels. For the regressions with
the non-binary smoking measures cigarettes per day and CO, the implied average effects of quitting smoking on BMI are presented in brackets. In other words, the numbers in brackets from the
cigarettes and CO regressions are comparable to the coefficient estimates from the quit status regressions. The row labeled “Hausman” gives the p-values from Hausman tests of the consistency
of the OLS estimator compared to IV. The sample sizes, provided in the row labeled “N”, vary
somewhat across specifications due to differing amounts of missing information. In unreported
regressions (available upon request), we re-estimated the models using only observations with no
missing smoking information and verified that any meaningful differences between the results cannot simply be attributed to the difference in samples.
The first column presents the short-run estimates using the quit dummy. The OLS regression
estimates that quitting smoking increases BMI by 1.295 units, or 8.2 pounds at the US average
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height of 66.55 inches.43 This is well within the range of estimates from the associational literature
discussed in Section 1. The IV estimate is a larger 2.202 BMI units, and the Hausman test strongly
rejects the consistency of OLS. This IV estimate equates to 13.9 pounds, which is larger than most
estimates of the average short-run weight gain from quitting smoking from the associational literature.
The next two columns use the smoking measures that incorporate intensity: cigarettes per day
and CO. In the IV specifications, we estimate that in the short run an additional cigarette smoked
per day reduces BMI by 0.052 units while an additional ppm of CO reduces BMI by 0.077 units.
The average effects of quitting smoking implied by these two regressions are 1.52 and 1.71 BMI
units, which translate to 9.6 and 10.8 pounds at the mean height. These estimates are 31% and
22% smaller than the 13.9 pounds we obtained using the quit dummy. This is consistent with our
prediction that neglecting to account for smoking intensity leads to an exaggerated IV estimate of
the average weight gain from quitting smoking.
The last three columns turn to the long-run estimates. The key result is that the long-run effects
are slightly stronger than the short-run effects. This is an important result, as the issue of whether the
effect diminishes over time has been a point of contention in the associational literature, as discussed
in Section 1. In the IV specification using average quit status, quitting for all five follow-up years is
estimated to increase BMI by 2.646 units, or 16.7 pounds. An additional cigarette smoked per day
over the five years reduces BMI by 0.065 units, while an additional ppm of average CO reduces BMI
by 0.082 units. These latter two estimates imply average weight gains from quitting smoking of
1.91 and 1.81 units of BMI, or 12.0 and 11.4 pounds. As with the short-run estimates, these results
suggest that incorporating smoking intensity is necessary to avoid overstating the magnitude of the
weight gain from smoking cessation.

We can use these long-run results to estimate the percentage of the rise in BMI that can be
attributed to falling smoking, under the admittedly strong assumption that the results generalize.
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Average height is computed by taking a simple average of the male and female heights given by
http://www.cdc.gov/nchs/fastats/body-measurements.htm.
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Table 12: Parametric Regression Results
Short Run (BMI Year 1)
Quit
Cigarettes
CO
Panel A: Effects of Smoking Measures on BMI
OLS
1.295∗∗∗ -0.031∗∗∗ -0.032∗∗∗
(0.047)
(0.001)
(0.002)
[0.91]
[0.72]
∗∗∗
∗∗∗
IV
2.202
-0.052
-0.077∗∗∗
(0.148)
(0.004)
(0.006)
[1.52]
[1.71]
Hausman
0.000
0.000
0.000

Long Run (BMI Year 5)
Average Average Average
Quit
Cigarettes
CO
2.299∗∗∗
(0.077)
2.646∗∗∗
(0.285)
0.211

-0.052∗∗∗
(0.002)
[1.52]
-0.065∗∗∗
(0.007)
[1.91]
0.047

-0.060∗∗∗
(0.003)
[1.33]
-0.082∗∗∗
(0.011)
[1.81]
0.030

Panel B: Effects of Treatment Dummies on Smoking Measures (First Stage of IV)
SI-A
0.277∗∗∗ -11.952∗∗∗ -8.025∗∗∗
0.206∗∗∗ -9.092∗∗∗ -6.634∗∗∗
(0.013)
(0.489)
(0.464)
(0.012)
(0.431)
(0.416)
∗∗∗
∗∗∗
∗∗∗
∗∗∗
∗∗∗
SI-P
0.272
-11.390
-7.728
0.211
-8.874
-6.380∗∗∗
(0.013)
(0.495)
(0.472)
(0.012)
(0.437)
(0.417)
F Statistic
320.6
371.1
190.3
227.8
284.3
163.6
N

5345

5344

5274

5446

4966

4517

Notes: Heteroskedasticity-robust standard errors are in parentheses. ***,** and * indicate
significance at the 0.1, 1, and 5 percent levels. For the non-binary smoking measures, the
implied average effect of quitting smoking is in brackets. The controls for education, gender,
marital status, age, and baseline BMI are included in all regressions.
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This percentage is given by

dbmi ∆cigday
dcigday ∆bmi

∗ 100%. For

dbmi
,
dcigday

we use the long-run IV estimate

for cigarettes smoked per day: -0.065. ∆cigday and ∆bmi are the changes in the population
means of cigarettes smoked per day and BMI among those at least eighteen years old. We compute
these using the oldest and newest waves of the National Health and Nutrition Examination Survey (NHANES) that contain data on both smoking (self-reported) and BMI (medically measured):
1971-1974 (NHANES I) and 2011-2012. This period spans the entirety of the sharp rise in obesity,
which did not begin until the late 1970s. During this time frame, average cigarettes smoked per
day fell from 9.165 to 2.188, so ∆cigday = 6.977. Average BMI rose from 25.425 to 28.617, so
∆bmi = 3.192. Plugging in these numbers suggests that the drop in smoking explains 14.2% of
the rise in BMI. We view this as a relatively substantial contribution to the trend. Courtemanche
et al. (2015) examine the extent to which 27 different economic factors contributed to the rise in
BMI, finding that the increased prevalence of big box grocers and restaurants explain 17% and
12%, respectively, while no other factors explain more than 4%.
Finally, the first-stage estimates in Panel B of Table 12 show that the treatment was effective
in reducing smoking. In the short run, being assigned into the SI-A or SI-P groups increased the
probability of quitting by 27-28 percentage points while decreasing cigarettes smoked per day by
11-12 and CO level by 8 ppm. In the long run, SI-A or SI-P assignment increased the fraction of
the five follow-up years quit by 0.21 while decreasing average cigarettes per day by 9 and average
CO by 6-7 ppm. The treatment variables are all highly significant in the first stage and the Fstatistics from the test of their joint significance are easily large enough to conclude that they are
sufficiently strong instruments. Also noteworthy is the fact that there is essentially no difference in
the coefficient estimates for the two treatment variables; in other words, the inhaled bronchodilator
given to the SI-A group did not influence smoking. This also means that, though our IV model is
technically overidentified, the instruments are not sufficiently distinct to make an overidentification
test informative or to consider instrumenting for two endogenous variables.
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Falsification Tests
We next conduct falsification tests to support our contention that the IV results using cigarettes per
day and CO are more credible than those using the quit dummy. In our IV models, the identifying
assumption is that the randomized treatment only influences BMI via the smoking variable. Our
falsification tests evaluate this assumption by asking whether the instruments influence the BMIs
of individuals who did not change their smoking habits during the sample period, according to each
smoking measure. A significant association would provide evidence that the randomized intervention influenced BMI through pathways other than the particular smoking measure, invalidating the
causal interpretation of the corresponding IV estimate. For the quit measure, we restrict the sample
to those with values of 0, meaning those who smoked in the first follow-up wave for the shortrun analysis and those who smoked in all five follow-up waves for the long-run analysis. For the
continuous smoking measures, there are obviously very few individuals with literally no change in
smoking across the sample period (i.e. the exact same number of cigarettes smoked per day/CO
level in the baseline period as in the follow-up waves), so a judgment call is required as to what
magnitude change in smoking should be considered ”meaningful”. We report results restricting the
sample to those whose post-treatment level of smoking is within 25% of their baseline level; results using neighboring cutoffs are similar. Using these subsamples, we estimate the reduced-form
version of the short- and long-run IV models; i.e. we regress BMI on the two treatment variables
plus the controls.
Ex ante, our prediction is that the binary quit measure will perform the worst in the falsification
tests since it leaves people in the sample who did actually experience a meaningful change in smoking but did not quit entirely. Note that it is not obvious that the falsification tests will produce null
results even for the smoking measures that incorporate intensity, though, since it is conceivable that
the treatment could affect BMI through pathways other than smoking. For instance, perhaps being
exposed to an intensive health-related intervention might increase some people’s level of general
health consciousness, which could lead to improved health behaviors along other dimensions besides smoking. The falsification tests are therefore important in assessing whether even our most
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conservative estimates of the effect of smoking on weight can be given a causal interpretation.
Table 13 reports the results. The left half of the table presents the results from the short-run
falsification tests (“effects” of the treatment dummies on year 1 BMI for those with unchanged
smoking status) while the right half shows the long-run results (year 5 BMI). For comparison purposes, the first column of each half of the table presents the reduced-form results for the full sample.
The remaining three columns of each half include those with no meaningful changes in the quit,
cigarettes per day, and CO variables, respectively. The sample sizes in the tests based on cigarettes
per day are smaller than those using quit status simply because more individuals are excluded as
the measure of smoking becomes more comprehensive. The sample sizes in the two columns using CO are very small because, as discussed previously, much of the sample is missing baseline
CO information, preventing the calculation of the percentage change. The falsification tests using
cigarettes per day are therefore much more highly powered – and consequently more informative
– than those using CO.
The columns labeled “full sample” show that, in both the short and long run, the reduced-form
effects of the two treatment variables on BMI are between 0.54 and 0.61 before excluding any observations. Dropping those who quit smoking reduces the magnitude of these effects by about half,
but significant effects of 0.21-0.28 remain. There is therefore clear evidence that the intervention
affected BMI through a pathway besides quitting smoking, implying that the IV estimates using
quitting smoking are too large. The falsification test results are much more favorable if we also exclude those with meaningful (>25%) changes in smoking intensity. In the two regressions that use
cigarettes per day, the coefficient estimates for the treatment variables are small (between -0.014
and 0.091) and highly statistically insignificant. There is therefore no evidence that the exclusion
restriction in the IV model is violated if cigday is used as the smoking measure. Excluding on the
basis of changes in CO also leads to highly insignificant effects, with three being negative (the opposite direction of the full-sample relationship) and one positive. The estimates are imprecise due
to the small sample size, so these results are not as compelling as those using cigday, but the lack
of a clear pattern is at least somewhat reassuring. To summarize, the results in this section suggest
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Table 13: Falsification Test Results
Short Run (BMI Year 1)
Full
Quit=0
<25%
<25%
Sample
Change Change
in Cigs. in CO
SI-A
SI-P
N

0.596∗∗∗
(0.048)
0.614∗∗∗
(0.049)
5345

0.278∗∗∗
(0.051)
0.214∗∗∗
(0.052)
3812

0.091
(0.130)
0.049
(0.127)
1703

-0.253
(0.365)
-0.127
(0.378)
231

Long Run (BMI Year 5)
Full
Average <25%
<25%
Sample Quit=0 Change Change
in Avg. in Avg.
Cigs.
CO
∗∗∗
∗
0.541
0.210
0.086
-0.368
(0.075) (0.082) (0.121) (0.342)
0.561∗∗∗ 0.252∗∗ -0.014
0.204
(0.074) (0.084) (0.118) (0.367)
5446
2958
1379
211

See notes for Table 12.

that while the IV results using the quitting indicator are contaminated by an alternative effect, the
results using both number of cigarettes and CO levels are more reliable.

Semi-Parametric Estimation
An issue with the parametric regressions for cigday and CO is that they assume that smoking
intensity affects BMI linearly. This is a strong assumption, as it seems likely that there is either a non-linear dose-response effect of nicotine on metabolism/appetite or a non-linear effect of
metabolism/appetite on weight-related behaviors. While it is not clear that this will bias estimates
of the average weight gain from quitting smoking, such a restrictive functional form is likely to lead
to systematically inappropriate predictions for at least some individuals. Moreover, given the complicated chain of biological and behavioral pathways through which smoking influences BMI, the
nature of the non-linearity is not clear ex ante. In other words, it is not obvious that the non-linearity
could be captured through simple approaches such as logarithmic or quadratic specifications. We
therefore next estimate a semi-parametric model that allows the data to determine the functional
form of the relationship between smoking and BMI. Specifically, we implement Robinson’s (1988)
semi-parametric double residual estimator with local smoothing. This approach allows us to model
the expectation of the dependent variable at every point on the distribution of the independent variable, thereby enabling the prediction of the weight gained (or lost) from switching from any level
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of smoking to any other level.44
Semi-parametric IV models can be estimated using a control function approach (Blundell and
Powell, 2004; Lee, 2007). The first stage takes the same form as equation (5). The second stage
differs from equation (4) in two ways. First, it does not specify the functional form for the smoking
measure. Second, rather than using the predicted value of the smoking variable from the first-stage
regression, the second stage includes the residual from the first stage as a regressor.45 The second
stage short-run regression can therefore be expressed as
bmii1 = β0 + β1 bmii0 + f (Si ) + β2 Xi + β3 µ
bi + εi

(9)

where S is either cigday or CO and µ
b is the first-stage residual. The second stage long-run regression is similar but replaces bmii1 with bmii5 and Si with the average smoking measures discussed
previously.
The estimation was conducted using the Stata program “semipar” by Deparsy and Verardi
(2012). The first step is to estimate E(bmi|S), E(µ|S) and E(X|S), which are approximated by
d µ
b by a kernel weighted local polynomial regression. The second
the predicted values bmi,
b, and X
d µ
b µ
step is to form the residuals µ
b1 = bmi − bmi,
b2 = X − X,
b3 = µ − µ
b. Then the coefficients
βb0 , βb1 , βb2 , and βb3 , representing the relationships between the independent variables and BMI, are
estimated by regressing µ
b1 on µ
b2 and µ
b3 . Thus, all parameters in equation (9) are identified except
the relationship between cigarette consumption and BMI. The last step is, therefore, to identify this
relationship with a non-parametric regression of cigarette consumption on the predicted BMI residˆ i1 − βb0 − βb1 bmii0 − βb2 Xi − βb3 µ
ual, bmi
bi . This relationship is estimated at every level of cigarette
smoking, allowing independent marginal effects. The idea behind this strategy is to estimate the
non-parametric cigarette function by the residual variation that is unrelated to the parametric independent variables.
44

For simplicity, we round smoking values to the nearest integer; e.g. if someone averaged 21.2 cigarettes per day
over the five follow-up waves we round this to 21.
45
For an overview of the control function approach to dealing with endogeneity, see Heckman (1979) and Heckman
and Robb (1986).
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We calculate the average effect of quitting smoking on BMI using the semi-parametric estimates
as follows. When using the cigarettes smoked per day variable, we first calculate the change in
predicted weight from switching from the number of cigarettes smoked at baseline to zero. We then
take the average of these predicted changes across all individuals in the sample. The process for
the CO variable is similar; the only difference is that we compute the predicted effect of switching
to the average CO level for non-smokers of 3.61 ppm, as opposed to zero.
In semi-parametric estimation, the confidence interval becomes very wide at extreme values
where there are very few observations. We therefore drop the top 1% of the smoking distribution,
which means those who smoke more than 50 cigarettes per day on average across the five follow
up years and those with average CO levels of over 50 ppm. We doubt that this restriction is consequential, since if we drop the same individuals in the parametric regressions the results (available
upon request) remain similar.
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Figure 4: Estimated Short-Run Effect of Cigarettes Per Day on BMI from Semi-Parametric
Model
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Figure 5: Estimated Short-Run Effect of CO Level on BMI from Semi-Parametric Model
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Figures 4 and 5 present the short-run semi-parametric IV results for cigday and CO, respectively. The graphs display both the point estimates for each integer level of smoking and the 95%
confidence intervals.Figure 2 shows that the short-run relationship between cigarettes smoked per
day and BMI is highly nonlinear. Specifically, smoking has a diminishing marginal effect on BMI
throughout most of the distribution, with the shape of the curve being approximately quadratic.
Quitting smoking from levels of 10, 20, 30, and 40 cigarettes per day is predicted to lead to weight
gains of 1.22, 1.58, 1.66, and 1.94 BMI units, respectively. Most of the effect of smoking on weight
therefore appears to occur at levels below 20 cigarettes per day. Taken literally, this would suggest that heavy smokers could cut back to a pack a day without fear of substantial weight gain.
Figure 3 shows that the short-run effect of CO on BMI is less obviously non-linear than the effect
of cigarettes per day. The curve is somewhat flat at very low levels of CO – specifically two to
five ppm – but recall that even non-smokers often have non-zero CO so changes at such low levels
probably do not reflect changes in smoking behavior. Starting at five ppm, the graph begins to take
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a quadratic shape, but unlike the graph for cigarettes per day we do not observe a complete leveling
off until the far right tail of the distribution.
Figures 6 and 7 turn to the long-run results using simple averages of the smoking measures; the
graphs using weighted averages are very similar and are available upon request. Figure 6 shows
that the shape of the long-run relationship between cigarettes per day and BMI is roughly similar to
the shape of the short-run relationship, as it is approximately quadratic and levels off at around 20
cigarettes per day. Figure 5 displays a similar pattern of results for CO level. CO has a diminishing
marginal effect on BMI, and most of the weight gain from reduced CO comes at levels below about
20 ppm. The long-run relationship between CO and BMI therefore flattens out more quickly than
the short-run relationship.46
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Figure 6: Estimated Long-Run Effect of Simple Average Cigarettes Per Day on BMI from
Semi-Parametric Model
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Note that there is some evidence that additional CO actually leads to higher BMI at the far right tail of the distribution: CO levels of around 47-50 ppm. However, this should be interpreted with caution as it is based on a very
small number of individuals. Accordingly, the confidence intervals in this portion of the distribution are quite large.
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The average effects of quitting smoking on BMI implied by these semi-parametric graphs are
generally similar to those from the parametric specifications. Using cigarettes per day, the average
effect of quitting is 1.67 BMI units in the short run and 1.93 in the long run, compared to 1.52 and
1.91 from the corresponding parametric regressions. For CO, the average effect is 1.80 in the short
run and 1.99 in the long run, compared to the parametric regressions’ estimates of 1.33 and 1.81.
The results presented in this section suggest that the marginal effect of smoking on weight is likely
to be modest for levels of smoking above 20 cigarettes a day, which would be impossible to detect
using linear specifications.
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Figure 7: Estimated Long-Run Effect of Simple Average CO on BMI from Semi-Parametric
Model
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Subsample Analyses
We next conduct subsample analyses to evaluate whether the effect of smoking on BMI differs by
age, gender, education, or baseline BMI. Heterogeneous effects could occur because of differences
in either the biological effects of nicotine on appetite or metabolism or the behavioral responses to
these biological effects. Given the complicated nature of these relationships, we make no ex ante
predictions about the patterns of heterogeneity. For age, we split the sample into three groups: those
under 45, 45-54, and 55 and over at baseline. We use these splits because there are no individuals
under 35 or over 64 in the LHS. For education, we consider subsamples of those with no college
education, some college, and a four-year college degree or greater. There are not enough individuals
with less than a high school degree or greater than a college degree to enable further stratification.
For baseline BMI, we are interested in whether quitting smoking leads to larger weight gains among
those who were already at risk of weight-related ailments prior to the intervention. We therefore
split the sample into those with healthy weights at baseline (BMI<25) and those who were already
overweight or obese (BMI≥25).
Table 14 displays the results for cigarettes per day (Panel A) and CO (Panel B). For brevity,
Table 14 contains only the results from long-run parametric IV regressions using simple averages
of the smoking measures. Semi-parametric graphs for each subsample are available in Appendix
Tables A1-A4. Short-run estimates and those using weighted rather than simple averages lead to
broadly similar conclusions and are available upon request.
The results suggest that the effect of smoking on weight is strongest for younger individuals,
women, those without a college degree, and those with healthy baseline BMIs. Quitting smoking
leads to an average weight gain of 2.19-2.21 BMI units for those under 45, 1.88-1.98 for 45-54 year
olds, and 1.33-1.45 for those 55 and older. One possible explanation is that the health consequences
from obesity become more salient with age, so older individuals may have a stronger incentive than
others to mitigate weight gain after smoking cessation. Again averaging over the four specifications, the average effect of quitting smoking on BMI is 2.04-2.45 units for women compared to
1.56-1.59 for men. Stratifying by education, the average effects of smoking cessation are around
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1.83-1.98 for those with no college education, 1.82-1.93 for those with some college but no degree,
and 1.64-1.73 for those with a college degree. There is therefore some evidence of a small reduction in the effect of smoking on weight as education rises, with the largest gap being between those
without a college degree and those with a degree. Perhaps education enables individuals to limit
weight gain through an improved understanding of nutrition and exercise. Alternatively, education
is correlated with income, and additional income may enable the purchase of healthier foods, gym
memberships, or over-the-counter products that can help counteract weight gain. Finally, the average weight gain from quitting smoking is 1.98-2.05 BMI units for people with healthy baseline
BMI levels compared to 1.7-1.82 for those who started the study overweight or obese. This result
suggests that individuals who are at higher risk of health consequences from weight gain take more
steps than others to limit the amount of weight gained after smoking cessation.
In all, though, perhaps the most striking results from Tables 14-15 is that, while some heterogeneity appears to exist, the overall amount of heterogeneity is relatively small. Negative and
highly significant effects of smoking on weight are evident for all subsamples. The smallest average effect of quitting smoking on BMI from any specification (55 and over, parametric, CO) is
a still sizable 1.33. The lack of substantial heterogeneity in the effect within the sample provides
perhaps some assurances that the results are generalizable outside the sample. The next section
evaluates the generalizability issue in more detail.

External Validity
We next perform some checks related to external validity. One obvious concern about the generalizability of the results is that the LHS was conducted in the early 1990s, raising the question of
the relevance for current policy debates. (With that said, many of the frequently cited associational
estimates are from studies using data that are as old or older.) Another concern related to generalizability is that the LHS’ participants are not a random sample of smokers: participants had to desire
to quit smoking, have mild (but not major) lung function impairment, and live within reasonable
proximity of the locations for follow-up visits. As discussed in the Data section, the end result was
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Table 14: Subsample Results for Age and Gender

N

(IV with Year 5 BMI Only)
Age
<45
45 to 54
≥55
∗∗∗
∗∗∗
-0.074
-0.066
-0.052∗∗∗
(0.014)
(0.010)
(0.015)
[2.21]
[1.98]
[1.45]
1514
2275
1177

Gender
Women
Men
∗∗∗
-0.091
-0.051∗∗∗
(0.015)
(0.008)
[2.45]
[1.56]
1894
3072

N

-0.093∗∗∗
(0.021)
[2.19]
1374

-0.101∗∗∗
(0.020)
[2.04]
1714

Average Cigarettes

Average CO

-0.083∗∗∗
(0.015)
[1.88]
2065

-0.069∗∗∗
(0.021)
[1.33]
1078

-0.069∗∗∗
(0.012)
[1.59]
2803

See notes from Table 12.

a sample that was almost exclusively white (97%) and exclusively middle-aged (starting age 35-59,
ending age 40-64).
We attempt to at least somewhat alleviate these concerns by conducting additional analyses with
the National Health Interview Survey (NHIS), a large nationally representative survey conducted
annually by the Centers for Disease Control and Prevention. The NHIS contains self-reported data
on smoking, weight, and height, along with the same control variables used in our LHS analyses
(except for baseline BMI, since the NHIS is not a panel). We use the NHIS to see if the association
between cigarettes smoked per day and BMI varies along the dimensions of the generalizability
issues: time period, race, and age. Obviously a causal analysis is not possible with the NHIS, but
verifying that the association between smoking and weight is not particularly unique among the
LHS population should provide at least some assurance that the causal effect is not likely to be
unique either. We first estimate the association among the NHIS’ best available analog to the LHS
sample: white 35-64 year olds in 1990-1994 (the years of the five LHS follow-up waves). We
then evaluate whether this association has changed over time by estimating the same model among
35-64 year old whites in the five most recent NHIS waves currently available: 2009-2013. Next,
we examine the issue of lack of representativeness by race by returning to the 1990-1994 NHIS
waves and restricting the sample to 35-64 year old non-whites. Finally, we estimate the model for
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Table 15: Subsample Results for Education and Baseline BMI

N

(IV with Year 5 BMI Only)
Education
No
Some
College
College
College Graduate
∗∗∗
-0.068
-0.065∗∗∗ -0.059∗∗∗
(0.011)
(0.014)
(0.013)
[1.98]
[1.93]
[1.73]
2082
1722
1162

-0.072∗∗∗
(0.010)
[2.05]
2369

-0.061∗∗∗
(0.011)
[1.82]
2597

N

-0.088∗∗∗
(0.016)
[1.83]
1895

-0.090∗∗∗
(0.014)
[1.98]
2161

-0.077∗∗∗
(0.016)
[1.70]
2356

Average Cigarettes

Average CO

-0.080∗∗∗
(0.021)
[1.82]
1555

-0.071∗∗∗
[0.019]
[1.64]
1067

Baseline BMI
< 25
≥ 25

See notes from Table 12.

whites of an age outside of the 35-64 range (i.e. 18-34 year olds combined with those 65+) in order
to evaluate the implications of the lack of representativeness by age.47
Table 16 reports the results. The first column shows that, in the sample most comparable to the
LHS, each additional cigarette smoked per day is associated with a reduction in BMI of 0.038 units.
This implies an average weight gain from quitting smoking of 0.8 BMI units. The second column
shows that the association between cigarettes smoked per day and BMI is stronger in the 2009-2013
sample than the 1990-1994 sample (-0.061 compared to -0.038), but the average effects of quitting
smoking are nonetheless fairly similar (0.91 BMI units compared to 0.8) which is similar to the
short-run OLS estimate from the LHS. This is because the average number of cigarettes smoked
among smokers has dropped over the past two decades. In other words, β2 may have grown over
)
(N
∑
time but cigday has shrunk for the average smoker, leaving
β2 cigdayi0 /N roughly constant.
i=1

Next, the third column provides evidence that the association between smoking and BMI for nonwhites is stronger than for whites, but the implied average effects of quitting smoking are similar.
Again, this is because on average non-white smokers consume fewer cigarettes than white smokers.
47
The associations of the control variables with BMI are very different for the 18-34 year old age group and the 65+
age group. Therefore, in the regression combining 18-34 year olds with those 65 and older, we include as additional
covariates the interactions of each control with an indicator for whether the individual is in the 18-34 portion of the
sample or the 65+ portion.
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Table 16: Comparison of Associations Between Smoking and BMI in Different NHIS
Samples

Cigarettes

N

(OLS Results Only)
1990-1994 2009-2013 1990-1994 1990-1994
White
White
Non-White
White
Age 35-64 Age 35-64 Age 35-64
Age Not
35-64
∗∗∗
∗∗∗
∗∗∗
-0.038
-0.061
-0.059
-0.040∗∗∗
(0.002)
(0.0 05)
(0.007)
(0.002)
[0.80]
[0.91]
[0.79]
[0.68]
51253
53136
10114
60424

Notes: The controls for education, gender, marital status, and age are
included in all regressions. NHIS sampling weights are used. See other
notes from Table 12.

The final column shows that the association between smoking and BMI among those who are not
between the ages of 35 and 64 is virtually identical to the association among those who are in
this age range. The average effect of quitting smoking is, however, slightly smaller among the
non-35-to-64 sample due to a lower number of cigarettes smoked among smokers.
In sum, though there is likely some heterogeneity across age, race, and time, these results provide at least some assurance that the lack of representativeness of the LHS is not driving our conclusions. Smoking is inversely associated with weight in all NHIS subsamples. The associations
between cigarettes smoked per day and BMI all fall within a reasonably tight range of -0.038 to
-0.061. The implied average effects of quitting smoking are all between 0.68 and 0.91 BMI units,
which equate to 4.3 to 5.7 pounds. These magnitudes are within the range found in the associational
literature and are well below the estimates from our LHS IV specifications. This underscores the
importance of accounting for endogeneity when evaluating the relationship between smoking and
weight.

Reconciling Our Results with Prior Literature
We close our empirical analysis by reconciling our results with those of EQ, who used previously
published LHS summary statistics from O’Hara et al. (1998) to estimate a very large 21.4 lb av66

erage weight gain from smoking cessation. We first replicate EQ’s results and then show that our
finding of a considerably smaller effect can be attributed to our use of more comprehensive smoking
measures.
We replicate EQ by computing a Wald IV estimate of the form

β̂W ALD =

bmi1 − bmi0
quit1 − quit0

(10)

where subscript one indicates the treatment group (combination of the SI-A and SI-P groups) and
zero the control group (UC). bmi1 and bmi0 are average BMIs among the treatment and control
groups, respectively, at the end of the study period (year 5). quit represents EQ’s measure of
quitting smoking, called “sustained quitting,” which is a dummy variable equal to one if and only
if the individual was a medically verified non-smoker in all five follow-up waves. This is a very
stringent measure, as anyone who smokes any amount in any of the five follow-up years is classified
as a non-quitter.
The validity of the Wald estimator hinges on the assumption that the intervention only affected
the weight of individuals for whom quit = 1. To the extent that the intervention also affected the
weight of any other individuals (i.e. those with quit = 0), the denominator will effectively be too
small. The observed difference in average weight between the treatment and control groups will
therefore be scaled by too small a number, and the estimated effect of quitting smoking on weight
will consequently be overstated. We suspect that the Wald estimator’s identifying assumption
is violated since there are two types of individuals categorized by EQ as having quit = 0 whose
smoking behavior (and therefore weight) likely responded to the intervention to at least some extent.
The first type consists of those who quit smoking for part but not all of the 5-year followup period. If, for instance, someone quit smoking for the first two years, relapsed in year three,
and then quit again for years four and five, this person is not classified as a quitter by EQ, but it
seems likely that they would have gained almost as much weight as someone who quit for all five
years. There are 1114 people in the treatment group who quit smoking in at least one follow up
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wave but were not sustained quitters. Therefore, not accounting for this group has the potential to
substantially impact the results.
The second type consists of those who reduced smoking but did not quit entirely. Given the
highly addictive nature of cigarettes, it seems likely that there are at least some people who were
able to cut back on their cigarette intake as a result of the intervention but were unable to quit
completely. Indeed, among those in the treatment group who never quit in any of the five followup waves, average cigarettes smoked per day still fell from 31 to 22. There is no reason to suspect
that the biological pathways through which smoking affects weight occur only along the extensive
margin of smoking, so people who cut back on smoking would likely experience at least some
amount of weight gain. Additionally, some people may also be a blend of the two types; e.g.
someone who responds to the intervention by gradually cutting back on smoking until successfully
quitting at the end of the third year.
After replicating EQ’s results using the “sustained quitting” variable, we then re-compute the
Wald estimate using our more nuanced long-run smoking measures discussed earlier in Section
3.1.2. Our “average quitter” measure addresses the issue of people who quit in some but not all
follow-up years. The average cigarettes per day and average CO variables also address the issue of
cutting back but not quitting entirely.
Table 17 reports the results. The first column shows that, replicating EQ’s Wald estimator,
we obtain an average estimated weight gain from quitting smoking of 3.196 BMI units, or 20.13
lbs at the average height. This is very similar to the result obtained by EQ, differing slightly because EQ used weight as the dependent variable rather than BMI. (We are unable to directly use
weight because the LHS microdata suppress height and weight and only provide BMI.) The second
column shows that using simple average quitter rather than sustained quitter reduces the average
estimated weight gain from quitting smoking by about 17% to 2.655 BMI units. In the last two
columns, we see that using the simple averages of cigarettes per day and CO attenuates this magnitude even further, to 1.84 and 1.58 BMI units, respectively. Ultimately, then, accounting for
both temporary/delayed quitting and smoking intensity reduces the estimated average weight gain
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Table 17: Reconciling Our Results with those of EQ
(IV with Year 5 BMI Only)
Sustained Average Average Average
Quit (EQ)
Quit
Cigarettes
CO
∗∗∗
∗∗∗
∗∗∗
Smoking Variable
3.196
2.655
-0.063
-0.072∗∗∗
(0.736)
(0.605)
(0.015)
(0.021)
[1.84]
[1.58]
N
5446
5446
4966
4517
Notes: No control variables are included. See other notes for Table 12.

from smoking cessation by 42%-51% relative to using the naive sustained quitter measure. Since
the Wald estimates using our preferred smoking measures from Table 17 are quite similar to those
from our preferred long-run specifications in Table 12, we conclude that the difference between our
results and those of EQ is due to the different smoking measures rather than our use of a covariateadjusted regression model in Table 12. This is not surprising given the randomized design. Note,
however, that the standard errors are lower in Table 12, so including covariates is still beneficial in
that it improves the precision of the estimates.

Conclusion
This paper aimed to provide the most credible answers to date to several questions related to the
relationship between smoking and weight. First, what is the average short-run causal effect of quitting smoking on body weight? Our preferred estimates suggest that this effect is around 1.5-1.7
BMI units, or 10-11 pounds at the average height. Second, does the weight gain from quitting
smoking disappear over time? The answer appears to be no, as the weight gain actually becomes
slightly larger in the long run. The long-run effect is around 11-12 pounds, which implies that the
fall in smoking explains about 14% of the rise in obesity in recent decades. Third, how does the
impact of smoking on weight vary across the smoking distribution? We find evidence of a diminishing marginal effect, with additional smoking having little long-run impact beyond about a pack
of cigarettes per day or a CO level of 20 ppm. Finally, how does the effect of smoking on weight
vary by age, gender, education, and baseline BMI? Our results suggest that, while quitting smoking
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leads to sizeable weight gain for all subsamples, the impacts are largest for younger individuals,
females, those with no college degree, and those with healthy baseline BMI levels.
Our estimated average effects of quitting smoking on weight fall within the range of estimates
from the associational public health literature, albiet toward the high end of the range. It is clear,
though, that our estimates are markedly smaller than those of EQ despite the fact that they utilized
the same randomized intervention. The fact that our results are closer to the associational estimates than to those of EQ illustrates a broader methodological point about the dangers of using IV
estimation uncritically even when the instrument is randomized or as-good-as-randomized. The
randomization merely ensures the validity of the estimated reduced-form relationship between the
instrument and outcome. Obtaining a reliable second-stage estimate requires the assumption that
the endogenous variable is the only pathway through which the randomized instrument affects the
outcome. This can be a difficult assumption to satisfy. As our paper shows, even if conceptually
there is only one pathway through which the intervention can plausibly impact the outcome, careful
measurement of that pathway is critical.
Our results also have interesting implications for the economics literature on tobacco control
policies. As discussed in the introduction, the literature on the effect of cigarette costs (prices or
taxes) on BMI reaches conflicting conclusions, with several studies suggesting the effect is either
very small or negative – implying that quitting or reducing smoking actually leads to weight loss.
Is it possible that the causal effect of an aggressive smoking cessation program is to increase BMI
while the casual effect of higher cigarette costs is either zero or negative? This seems conceivable
for two reasons.
First, the LATE from a price-induced reduction in smoking may differ from the LATEs from
smoking ban-induced or aggressive smoking cessation program-induced reductions in smoking.
Different smokers could be affected by these different types of interventions; for instance, it seems
reasonable to think marginal smokers would be the ones to respond to cigarette price increases
whereas those with strong addictions would be the ones to volunteer for a comprehensive program.
Perhaps those with strong addictions are relatively more likely to “quit at all costs”, even if it means
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gaining a substantial amount of weight.
Second, perhaps cigarette prices/taxes affect BMI through pathways besides smoking behavior.
In other words, people who quit smoking in response to higher cigarette prices may gain weight,
but this could be counteracted by weight losses among those whose cigarette consumption is unchanged – a large share of the population given the price inelasticity of cigarettes (Chalopuka and
Warner, 2000). Smokers who do not reduce their consumption when prices rise experience potentially sizeable negative income effects, which could lead to weight loss by reducing overall food
consumption or frequency of eating out at restaurants. Moreover, cigarette taxes generate revenue for the state, which can be used to provide funding for nutrition education or health-related
programs such as Medicaid. These, in turn, could reduce the BMIs of even non-smokers.
To close, we should emphasize that our results should not be interpreted as suggesting that
individuals should be reluctant to quit smoking out of fear of gaining weight. The large body of
epidemiologic evidence that smoking is bad for health implies that any increase in obesity-related
ailments after quitting smoking is far outweighed by the health improvements along other dimensions. Instead, our findings should be interpreted as a call for further investigation into medical
and policy interventions that can limit the weight gain from smoking cessation. If this side effect
of an otherwise healthy decision could be eliminated, it stands to reason that the health gains from
tobacco control efforts would become even greater.
To that end, Farley et al. (2012) provide a review of the literature on the effectiveness of various
interventions in limiting the weight gain after quitting smoking. Some evidence suggests that the
drugs dexfenfluramine, phenylpropanolamine, naltrexone, bupropion, and fluoxetine can reduce
weight gain in the short run, though there is insufficient evidence to draw clear conclusions about
whether the effects persist after the drugs are discontinued. Weight management education alone
does not seem to reduce weight gain and might actually hinder efforts to quit smoking, whereas
weight management education combined with personalized support appears more successful. For
all types of interventions reviewed by Farley et al. (2012), their ability to draw clear conclusions
was hindered by a lack of available research and small sample sizes in the studies that do exist.

71

Much more research is needed regarding which interventions can help limit weight gain following
smoking cessation as well as how best to incentivize (e.g. more generous insurance coverage)
interventions that prove effective.

III

Misreporting Smoking Status and Consequences for SelfReported Survey Data

Introduction
Smoking has been the number one cause of preventable death in the last 60 years. Today, the estimated cost of smoking totals 300 billion dollars per year in the US alone (2014 Surgeon General
Report). As a result, federal and state governments invest large amounts of resources to decrease
smoking participation. Over the past 50 years, smoking participation among U.S. adults has decreased by more than half, from around 40% in the mid-1960s to 20% by 2015 (CDC 2014).
Scientists and policymakers are interested in understanding how public policies contributed to
the decline in smoking. A large body of literature suggests that policies, such as cigarette tax increase and the introduction of smoke free zones, contributed substantially to the decline in smoking
(Carpenter et al. 2008, DeCicca et al. 2008, Levy et al. 2003, Evans 1999,). However, most of the
studies utilize self-reported smoking information. Self-reported smoking information can be misreported and therefore may lead to biased estimates. Overall, not much is known about the level of
misreporting and who misreports smoking status.
This paper analyzes misreporting in smoking status among adults. We utilize data from the
Lung Health Study (LHS), a randomized smoking cessation study that includes self-reported and
objectively verified smoking information. The data allows us to generate a binary misreporting variable capturing discrepancies between the self-reported and objectively verified smoking
variables.48 In our initial methodological approach we take the clinical smoking measure as the
48

Objectively verified smoking status is estimated based on Cotinine saliva and Carbon Monoxide (CO) tests during
the hospital visit.
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gold-standard. First, we address whether misreporting is a pure mechanical result of strict Carbon
Monoxide (CO) and Cotinine cutoff levels, where clinicians classify participants either as smokers
or non-smokers.49 Second, we evaluate whether misreporting differs by treatment group. In other
words, do participants who receive treatment misreport at different levels than those in the control group. Third, we regress our misreporting variable on demographic characteristics including
household smoking attributes. We also perform sub-sample analyses by treatment group.
In our second methodological approach we take an agnostic view on whether the objective
smoking measure should be preferred to the self-reported measure. We use objectively verified
BMI, CO and Cotinine data to inform whether a person is in reality a “true” smoker. We estimate a Bayesian mixture model which relaxes the assumption that observations are drawn from
one distribution, but rather two underlying distribution. We believe that the LHS is a well suited
dataset for this exercise for several reasons. First, the LHS consists of a sample of heavy smokers
at the beginning of the trial. Second, upon receiving the very effective smoking cessation treatment, many participants quit smoking, leading to significant weight gain and reduction in CO and
Cotinine levels in a short amount of time (Courtemanche et al. 2016). Thus, our post-treatment
data comprises a mixture of smokers and non-smokers, where on average, quitting smoking leads
to a significant increase in BMI, and reduction in CO and Cotinine levels relative to continuous
smokers. As a result, we infer whether participants who misreport smoking status belong to the
higher BMI distribution, and lower CO and lower Cotinine distributions. We also estimate whether
misreporters are more likely to be part of the non-smoking distribution of changes in BMI, CO, and
Cotinine levels relative to pre-treatment levels.
We believe that this paper contributes significantly to the economics literature. Currently there
is limited and mixed evidence on whether smokers misreport. As a result, papers analyzing smoking
behavior rarely discuss the problem of applying misreported smoking data. Most research uses selfreported information to identify causal effects in topics such as the relationship between cigarette
taxes and smoking participation (Tauras 2006, Chaloupka et al. 2000). This could potentially be a
49

CO is measured in parts-per-million (ppm) of exhaled air using either the MiniCO (Catalyst Research) or the EC50
(Vitalograph). Cotinine is measured from a saliva sample taken during the meeting
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problem since self-reported smoking status can be misreported between 3% to 70% (Brachet 2008,
Webb et al. 2003, Boyd et al. 1998). Similarly, Bound (1991) discusses that many self-reported
survey responses may be misreported in the same survey. Therefore, any analysis comparing several self-reported variables applies mismeasured independent and dependent variables. As a result,
conclusions from such data can be biased.50
Misreporting levels in smoking participation are less understood. In contrast to self-reported
public program participation which can be matched with administrative data, smoking information
can normally not be matched with administrative smoking information. There are several reasons
for missing administrative smoking information. First, governments have public program participation information, as they need to know who they are paying benefits to, but collecting information on “correct” smoking participation requires tax resources without any tangible benefits to the
government. Second, surveys collecting self-reported information are much more cost effective
in accumulating information for a large sample of the population. As a result, self-reported and
clinically verified smoking information are most commonly available in Randomized Controlled
Trials (RCT).
Our descriptive analysis reveals that the number of treatment group participants misreporting
smoking status is twice as large as in the control group. We speculate that a treatment group participant’s knowledge of receiving treatment and the intended treatment goal may explain at least
a portion of the higher misreporting level in the treatment group. Second, our results show that
participants misreport across the CO and Cotinine level distributions, implying that clinicians take
into account additional information beyond CO and Cotinine levels to make decisions regarding
smoking status.
Our regression results show that being male, married and of older age significantly increases the
50
There is also a large literature analyzing the level of misreporting in social welfare programs such the Supplemental
Nutrition Assistance Program (SNAP) and Medicaid by matching self-reported survey information, such as the Current
Population Survey (CPS), with administrative data. Several papers show that misreporting, in this case under-reporting,
in SNAP participation can reach over 30% (Meyer et al. 2009). Additionally, The recognition of large levels of
misreporting lead to the development of new estimation strategies to recover unbiased coefficients under the presence
of misreporting (Kreider et al. (2012), Almada et al. 2015, Lewbel 2007, Nguimkeu et al. 2016).
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probability of misreporting, while having a higher BMI51 and consuming nicotine gum decreases
the probability of misreporting. For example, being male or married increases the probability of
misreporting by 10 percentage points. Our regression sub-sample analyses by smoking cessation
group present heterogeneous effects. We only find a significant relationship between misreporting, gender, marital status, nicotine gum use and BMI for those participants randomized into the
smoking cessation treatment group.
Our second methodological approach reveals two distinct distributions separating smokers from
non-smokers across outcome measure. For example, utilizing the change in BMI from baseline to
year 5 as the dependent variable, we find that the first distribution has an average of 0.21 BMI
units and the second distribution has an average of 1.56 BMI units, where smokers are much more
likely to be part of the first, small change in BMI, distribution (84%) and non-smokers are much
more likely to be part of the second higher BMI distribution (97%). Our analysis comparing the
distribution probabilities for those participants who were objectively classified as smokers, but
self-reported to be non-smokers, shows a 77% average probability of belonging to the high, large
change in BMI, distribution . As a result, even though they are objectively classified as smokers, the
participants are much more likely to be part of the higher BMI distribution. We rely on descriptive
statistics and the mixture model results to calculate that at least 29% of misreporters may be in fact
falsely classified as smokers.
The rest of the paper is organized as follows. Section 2 discusses the literature on misreporting
with an emphasis on under-reporting of program participation. Section 3 discusses the data. Sections 4-5 present the parametric and non-parametric estimation strategies and present the results.
Section 6 concludes.
51

Body Mass Index (BMI) is equal to weight in kg divided by height squared in centimeters. Revealing a measure
if someone’s weight is considered underweight, normal, overweight, or obese.
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Literature Review
There is a large empirical literature estimating misreporting levels in public program participation
and a smaller literature on smoking misreporting levels. Similarly, a growing literature proposes
methodology to recover unbiased estimates for misreported data. We discuss all of these aspects
with an emphasis on under-reporting also referred to as false negatives.
Many studies report that people misreport public program participation. The seminal study by
Meyer, Mok and Sullivan (2009) compares ten transfer programs in five different surveys.52 They
compare weighted self-reported survey data to records of administrative aggregates and find that
overall under-reporting is significant and has been increasing over time. It is particularly severe
for the workers compensation and the AFDC/TANF program where under-reporting reaches 50%
in surveys such as the PSID and CPS. Similarly, under-reporting for the food stamp program is
close to 40% in the PSID and SIPP. Other studies, such as Meyer & Goerge (2011) and Marquis &
Moore (1990 & 2010), find similar levels of under-reporting. Additionally, Bollinger and David
(1997) find that participation in food stamp programs is a particularly prone to being misreported
because of the social “stigma” associated with its program participation.
Under-reporting is not only confined to public program participation. Bound (1991) discusses
that self-reported survey responses may be misreported across the board. One explanation for
that can be that people misreport to mimic socially desirable behavior (Ansolabehere and Hersh
2012). Similarly, Card’s (1996) study finds significant under-reporting in union coverage as well.
Ezzati et al. (2006) show that women under-report their weight and middle aged men over-report
their height. Even in situations where socially desirable behavior might not be identifiable, underreporting is still large. Wolf (2004) takes advantage of GPS data and shows that people under-report
52
The programs they look at are Unemployment Insurance (UI), Workers’ Compensation (WC), Social Security
Retirement and Survivors Insurance (OASI) and Social Security Disability Insurance (SSDI), Supplemental Security
Income (SSI), the Food Stamp Program (FSP), the Earned Income Tax Credit (EITC), Aid to Families with Dependent
Children/Temporary Assistance for Needy Families (AFDC/TANF), the Special Supplemental Nutrition Program for
Women, Infants and Children (WIC) program and the National School Lunch Program (NSLP). The surveys are the
Current Population Survey – Annual Demographic File/Annual Social and Economic Supplement (CPS), the Survey
of Income and Program Participation (SIPP), the Panel Study of Income Dynamics (PSID), the American Community
Survey (ACS), and the Consumer Expenditure Interview Survey (CE Survey).
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the number of trips taken by car by 11% to 81%.
Less is known regarding the level of under-reporting of smoking behavior in the population.
Studying the level of misreporting relies on a comparison between self-reported and clinical smoking information, such as carbon monoxide or cotinine levels, nicotine’s main metabolite. However,
even if an objective measure is available, a clinician has to make a judgment call by defining cotinine and carbon monoxide thresholds after which a person is classified as a smoker. As a result, the
evidence on the level of misreporting is mixed. Evidence from samples of pregnant women show
that under-reporting reaches 35% while over-reporting reaches 10% (Brittonet al. 2004). Similarly, Boyd et al.(1998) & Bardy et al.(1993) report smoking under- and over-reporting in a sample
of pregnant women and neonatal mothers between 26-38% and 3-14%, respectively. One possible
explanation for under- and over-reporting may lie in the unequal thresholds that define a smoker
relative to a non-smoker. Nevertheless, it is surprising that all samples observe over-reporting in
smoking status, because we find no evidence in our sample. It could be explained by the demography of the sample. Another explanation for over-reporting may be that pregnant women only quit
smoking during pregnancy, and therefore still classify themselves as smokers.
A separate growing literature produces methodological work to recover unbiased estimators
in the presence of misreporting (Aigner 1973, Bollinger & David 1997, Hausman et al. 1998,
Brachet 2008). Mahajan (2006) and Hu & Schennach (2008) formalize a model for a mismeasured
binary independent variable and show that under certain assumptions correct marginal effects can
be obtained. Hug (2010) proposes a solution to misreporting with linear and non-linear estimation
techniques. McCarthy and Tchernis (2011) apply Bayesian methods to estimate consistent and
unbiased coefficients under misreported program participation. Lewbel (2007) as well as Mahajan
(2006) rely on an instrumental variable approach without the typical conditional independence
assumptions. Brachet (2008) proposes a two-stage estimator, similar to a two-part model, where
treatment effects are estimated in the second stage. Berg and Lien (2006) introduce a model that can
handle misreporting and non-response simultaneously. Lastly, Kreider et al. (2012) follow Manski
(1995) & Pepper (2000) to identify an average treatment effect bound rather than the parameter.
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Our paper contributes to both literatures.

Data
We use data from the the LHS, a randomized smoking cessation trial, to observe changes in the
severity of chronic obstructive pulmonary disease (COPD). The study recruited 5887 smokers with
initial ages between 35 and 59 at 10 clinical centers in the US and Canada. Recruitment lasted from
1986 to 1989 and the clinical trial ended in 1994. Participants were interviewed annually at a clinic
near their residence. The data includes the baseline year (1989) and the five annual follow-up years
(1990-94).53 Eligible smokers had to show signs of mild lung function impairment, have no history
of certain medications, consume less than 25 drinks per week, have a BMI under 40, and have no
severe illnesses or chronic medical conditions.
Participants were randomly assigned into treatment and control groups, with an additional randomization arm within the treatment group to receive either a bronchodilator with medical benefits
(SI-A) or a placebo inhaler (SI-P) with no medical benefits. Both treatment groups received a
special intervention (SI) focusing on a behavior intervention consisting of a physician message,
interventionist meetings, an intensive quit week, and frequent contact with support personnel with
invitations to bring a spouse or a relative to the meetings. Additionally, both treatment groups received free nicotine gum. Most of the intensive intervention treatments were completed within the
first 4 months of the study. The control group, or usual care (UC) group, received no intervention
and group members were referred to their own private sources for medical care.
We take advantage of information on BMI, Carbon Monoxide levels, Cotinine levels, smoking
behavior, family smoking habits, and demographic characteristics. BMI was calculated from measured weight and height by medical staff at the participants’ clinic visits. Information on smoking
behavior includes self-reported smoking status as well as self-reported average cigarette consumption per day. The data also includes a binary indicator measuring the objective smoking status
measured by a clinician who has access to information on CO and Cotinine levels taken from par53

Attrition was low, only 5% of participants did not interview in the final follow-up
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ticipants at each of the annual follow-up visits.54 We also utilize variables measuring self-reported
smoking participation in the household. Specifically, we have binary variables identifying if the
spouse smokes, if the child smokes, if anyone else smokes, and a continuous variable measuring
the number of smokers living with the participant. Lastly, we use information on education level,
gender, age, and marital status.
We utilize self-reported and objectively verified smoking variables to generate a measure of
a misreporting, a dummy variable quantifying whether the self-reported and objective smoking
information present conflicting evidence after the first annual follow-up visit. For example, the
misreporting variable equals one if participants report being a non-smoker while the objectively
verified measure suggests that the participant is a smoker and vice versa. The data show a clear sign
of under-reporting in smoking status (false negative) with no-one over-reporting smoking status.
In other words, some smokers report being a non-smoker while the objective measure suggests
otherwise.
Table 18 presents descriptive statistics for the treatment and control groups at the time of randomization. Across all groups the variables are balanced, suggesting that randomization was successful. The sample represents heavy smokers, consuming about 30 cigarettes per day and about
40% of participants had someone smoking in the household. This is expected because approximately 65% of participants were married and heavy smokers are more likely to have a spouse who
is also a smoker. The sample is on average more highly educated, 13.57 of completed years of education, than the general population of the early 90s. Additionally, the average age is 48, indicating
that we are most likely looking at heavy smokers that have been smoking for many years.
Table 19 presents descriptive statistics for the self-reported, the objective verified smoking
status, and the dependent variable measuring if those two aforementioned variables present conflicting results. In total 316 individuals are classified as misreporters, meaning that they self-report
that they do not smoke while the objective measure suggests that they are smoking. About 7% in
the treatment groups misreport smoking status and only 3% in the control group misreport smoking
54

Again, CO is measured in parts per million (ppm) and Cotinine is measured in nanograms per milliliter (ng/mL)
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Table 18: Summary Statistics by Treatment Group
Assignment at Randomization Meeting
Variable
Cigarettes per Day
Cotinine Level
Carbon Monoxide
BMI
Smoker in HH
HH Spouse Smokes
HH Child Smokes
HH Other Smokes
Education Level
Male
Married
Age
Observations

SI-A
SI-P
29.59
29.49
(14.08) (13.60)
367.07
369.42
(203.76) (200.04)
25.97
26.69
(13.48) (12.67)
25.42
25.67
(3.91)
(3.92)
0.39
0.40
(0.49)
(0.49)
0.27
0.29
(0.45)
(0.45)
0.13
0.11
(0.34)
(0.31)
0.06
0.05
(0.24)
(0.23)
13.57
13.56
(2.84)
(2.84)
0.60
0.64
(0.49)
(0.48)
0.65
0.67
(0.47)
(0.47)
48.41
48.55
(6.84)
(6.83)
1961
1962

UC
29.53
(14.11)
363.11
(204.82)
28.98
(12.67)
25.55
(3.92)
0.39
(0.49)
0.27
(0.44)
0.12
(0.32)
0.06
(0.23)
13.68
(2.79)
0.64
(0.48)
0.65
(0.47)
48.43
(6.80)
1964

Notes: Standard Deviations in Parentheses. SI-A and
SI-P are the treatment arms and UC is the control.
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status. The analysis by group assignment suggests that misreporting is related to treatment status.
The difference in misreporting levels by treatment group may also reflect differences in observable
characteristics among misreporters. For example, heavy smokers in the treatment group may be
more likely to misreport smoking status than those in the control group.
Table 19: Summary Statistics at First Follow-Up Visit
Variable
Self-reported Smoking Status

SI-A
SI-P
UC
0.56
0.57
0.88
(0.50) (0.50) (0.33)
Objectively verified Smoking Status 0.63
0.65
0.91
(0.48) (0.48) (0.29)
Mismeasured Smoking Status
0.07
0.07
0.03
(0.26) (0.25) (0.16)
Observations
1867 1866 1865
Notes: Standard Deviations in Parentheses. SI-A and SI-P are the
treatment arms and UC is the control.
There are concerns that the CO and Cotinine measures only represent short-term measures of
smoking status or possible exposure to second hand smoke. CO has a half-life of about 5 hours
while Cotinine has a half-life of about 7 days (Jo & Oh 2003). Therefore Cotinine levels should
reveal more accurate long-term smoking patterns. To this end, a typical approach in the literature
is to classify smokers as having a CO and Cotinine levels above 10ppm and 10 ng/mL, respectively (Carey & Abrams 1988). The Lung Health Study utilized thresholds of 10 ppm for CO and
20ng/mL for Cotinine (Murray et al. 1993). However, it is possible to have smokers with lower
concentrations, and e non-smokers with above threshold concentrations.55 A typical non-smoker
has a CO level below 4ppm (Deveci et al. 2004), but can have Cotinine levels of up to 30mg/ml
(Laugesen et al. 2009). Moreover, having non-smokers consume nicotine gum can also lead to
high levels of saliva Cotinine (Gross et al. 1995). Therefore, it is not easy to clearly separate
non-smokers from smokers considering that many factors affect CO and Cotinine levels.
We begin by comparing CO and Cotinine levels among objectively classified smokers, nonsmokers, and misreporters at the first annual follow-up visit, because this is the first time we can
55

For more information see http://www.healthnz.co.nz/CObreath.htm
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generate our misreporting measure. Figure 8 includes three graphs that includes reference lines for
the 10 ppm and 10ng/ml threshold limits for CO and Cotinine levels, respectively. The top left
graph shows that many smokers tend to have high CO and Cotinine levels, but there are also a few
smokers with CO and Cotinine levels below the thresholds of 10. Moreover, among non-smokers
(top right graph) we find very few participants with CO levels above 10 ppm, but a relatively
uniform distribution of Cotinine levels. The distribution of CO and Cotinine levels among misreporters mimics more closely the distribution of smokers, however, there are many misreporters
with CO levels below the typical 10 ppm threshold. Overall, Figure 8 suggests that CO seems to
be an important clinician measure whether somebody is classified as a smokers or not. Moreover,
the graphical evidence suggests that there are many misperoters with CO levels below the threshold that classifies them as smokers. Next we discuss our empirical strategy to identify whether
misreporters differ from non-smokers at the first annual follow-up visit.
Figure 8: CO and Cotinine Levels by Smoking and Misreporting Status at the First Annual
Follow-Up Visit
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Econometric Analysis
Regression Analysis
In our first approach we take the objective smoking status variables as accurately representing each
participant’s smoking status. We estimate regression models to identify how demographic variables, CO, and Cotinine levels correlate with misreporting status. Our motivation for this approach
is the following - if household smoking variables are positively correlated with misreporting, then
this could indicate that clinicians may misinterpret CO and Cotinine information. It is possible
that a non-smoker exposed to second-hand smoking reports a high CO level. Additionally, a nonsmoker consuming nicotine gum increases Cotinine levels significantly. Thus, if clinicians do not
account for these influences participants may be wrongly classified as misreporters. To this end,
we include a dummy variable for whether the participants consumed nicotine gum in the last 23
hours before the annual follow-up visit. We also include different types of dummy variables measuring household smoking. First, we include whether the person reports that they have a smoker
living with them. Second, we include a variable measuring the number of smokers in the household. Third, we include dummy variables for whether the spouse, child, or someone else smokes
in the household. Given the nature of our binary dependent variable, we estimate Probit and Linear
Probability Models (LPM). The basic LPM specification is given here:

Si1 = γ0 + γ1 HHi + γ2 Xi + µi1

(11)

where Si1 is a binary indicator measuring misreporting smoking status for individual i at the first
follow-up visit. In all of the regressions our references group are verified non-smokers, i.e nonmisreporters. HHi reflects a vector of binary household smoking information as outlined in the
data section and summarized in Table 18. We include different combinations of household smoking
variables in our regressions to test the robustness of our results. Xi includes education level, marital
status, age, nicotine gum use, and BMI of the individual. Similarly, we estimate equation (11) with
Probit and Logit models to estimates if the LPM results are robust to model specification.
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Parametric Results
Table 20 presents six regression estimates for equation (11), where each regression includes a
different set of household smoking characteristics. Column 1 includes the baseline model with no
household smoking variables, and columns 2-6 include different variables of household smoking
participation. In unreported Probit regressions we find that the marginal effects are not statistically
different from the LPM results.
Across specification we find that being older, married, and male increases the probability of
misreporting, while using nicotine gum and having a higher BMI decrease the probability of misreporting. Specifically, we find that being a married male increases the probability of misreporting
by about 10%. In contrast, consuming nicotine gum decreases the probability of misreporting by
7%. To put all results in perspective, about 14.9% of non-smokers are misreporting, suggesting
that the marginal effect presents large changes relative to the baseline misreporting level. To our
surprise all observable characteristics only explain a fraction of the variation in misreporting as
documented by the R-squared of only 0.03.
Next, we estimate sub-sample regression of equation (11) by treatment status. Table 20 presents
evidence that a larger proportion of treatment group participants misreport relative to the control
group. Thus, we also report results restricting the sample by treatment group in Appendix Tables
A6-8. Ex ante, we believe that the relationship between demographic characteristics and misreporting status can be different for these sub-samples for reasons discussed previously in the data
section.
Among the sub-sample results by treatment assignment, we find evidence in both treatment
group regressions that being male increase the probability of misreporting, while the use of nicotine gum and having a higher BMI decreases the probability of misreporting. Interestingly, we find
that the positive relationship between age and misreporting is only significant in the SIA treatment
group sub-sample in Table A6 and that the positive effect of being married on misreporting is only
significant in the SIP treatment group in Table A7. In the control group, we find that being of older
age and having a smoking spouse decreases misreporting, with some regression specifications pre84

Table 20: Regression Estimates on the Effect of Demographic Variables on Misreporting
Male
educ
Married
Age
BMI
Nicotine Gum
HH Smoker
# Smokers in HH
HH Spouse Smokes
HH Child Smokes

Dependent Variable: Misreporting Smoking Status
0.0651***
0.0646***
0.0650***
0.0650***
0.0667***
(0.0177)
(0.0177)
(0.0177)
(0.0177)
(0.0177)
-0.000531
-0.000714
-0.000584
-0.000608
-0.000221
(0.00310)
(0.00310)
(0.00310)
(0.00309)
(0.00307)
0.0297*
0.0305*
0.0300*
0.0325*
0.0323*
(0.0179)
(0.0179)
(0.0179)
(0.0182)
(0.0182)
0.00344*** 0.00343*** 0.00344*** 0.00345*** 0.00342***
(0.00126)
(0.00126)
(0.00126)
(0.00126)
(0.00126)
-0.00960*** -0.00957*** -0.00960*** -0.00960*** -0.00959***
(0.00214)
(0.00214)
(0.00214)
(0.00214)
(0.00214)
-0.0715*** -0.0723***
-0.0717***
-0.0730***
-0.0729***
(0.0171)
(0.0172)
(0.0171)
(0.0172)
(0.0173)
-0.0146
(0.0191)
-0.00355
(0.0147)
-0.0227
-0.0269
(0.0232)
(0.0231)
0.0435
(0.0301)

0.207**
(0.103)

0.213**
(0.103)

0.209**
(0.103)

0.210**
(0.103)

0.201**
(0.102)

-0.0265
(0.0231)
0.0450
(0.0302)
-0.0510
(0.0422)
0.207**
(0.103)

1,803
0.030

1,803
0.030

1,803
0.030

1,803
0.030

1,803
0.031

1,803
0.032

HH Other Smokes
Constant

Observations
R-squared

0.0669***
(0.0178)
-0.000279
(0.00307)
0.0292
(0.0185)
0.00339***
(0.00127)
-0.00960***
(0.00214)
-0.0724***
(0.0172)

Notes: Regressions include Heteroscedasticity robust standard errors in parentheses. Each column presents estimates for a different regression. Sample includes non-smokers and misreporters.
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senting a positive effect of being married on misreporting. We conclude that this is a profound
result because it implies that endogenous misreporting occurs by treatment group assignment. We
tested the hypothesis whether the marginal effects in the treatment group sub-samples are different from the control group, and find significant differences in the nicotine gum and HH spousal
smoking status variables.
In conclusion, we find that under-reporting in smoking participation is prevalent in the LHS
where participants know that they will be subjected to clinical tests. Our regression estimates
indicate that being male, married, and of older age increases the probability of misreporting, while
having a higher BMI and consuming nicotine gum decreases the probability of misreporting. Our
sup-sample analysis presents evidence for endogenous misreporting, emphasizing the need to apply
models that correct for endogenous misreporting. We believe that LHS treatment group participants
may feel social pressure to show that the smoking cessation program worked and therefore are more
likely to misreport than control group participants. However, overall the observable variables only
account for a small fraction of the variation that explains misreporting. Therefore, future research
needs to expand the set of control variables to explore other reasons for misreporting. In our next
step we analyze whether the objective smoking measure does a good job at identifying misreporters.

Are Misreporters Different from Non-Smokers and Smokers?
We begin the second part of the paper to analyze whether misreporters are different from smokers
and non-smokers. Specifically, we compare the means of several smoking variables (Cigarettes
per Day, CO and Cotinine levels at baseline) for misreporters to smokers and non-smokers. If
misreporters are more similar to smokers than non-smoker, then this provides some evidence that
clinicians correctly identified misreporters.
Table 21 summarizes observable smoking characteristics at the baseline meeting for all misreporters by treatment group and compares them to baseline characteristics of participants classified
as smokers and non-smokers by the first annual follow-up visit. We find that the mean cigarette
consumption of misreporters is statistically different from the mean cigarette consumption of smok-
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ers. Specifically, misreporters consume about 2 cigarettes less cigarettes at the baseline interview
compared to those who smoke. There is also evidence, that misreporters consume less cigarettes
per day than non-smokers. Since misreporters consume less cigarettes at baseline than smokers
and non-smokers it is conceivable that a good proportion of misreporters was able to quit smoking
or reduce cigarette consumption significantly.
Table 21: Summary Statistic at Randomization for Participants who Misreport
by Treatment Group
Cigarettes per Day
CO Baseline Visit
CO Screening Visit*
Cotinine level
Observations

SI-A
26.76*
(12.87)
33.46
(16.11)
26.3
(14.09)
368.54
(180.73)
138

SI-P
25.66*
(14.11)
32.06
(17.85)
27.5
(13.79)
368.34
(203.70)
130

UC
Non-Smokers
23.83*
27.95
(13.18)
(14.39)
N/A
30.88
N/A
(17.47)
30.5
25.28
(14.46)
(13.57)
433.02*
341.33
(341.86)
(207.80)
48
1539

Smokers
30.45
(13.69)
34.15
(16.48)
26.52
(12.58)
375.52
(198.63)
4019

Notes: Standard deviation in parentheses. SI-A and SI-P are the treatment arms and
UC is the control arm. * implies that only a fraction of the misreporters observations
are available 25,18,10, respectively, and also that the mean is significantly different at
the 5% level from the mean of smokers. Smokers and non-smokers are defined by their
smoking status at the first annual follow-up visit.
We continue our descriptive analysis by comparing the changes from the baseline year to the
first annual follow-up visit in average BMI, Cotinine, and CO levels for misreporters to smokers
and non-smokers. Table 22 summarizes the changes for all variables by group. T-tests suggest that
almost all means among misreporters are significantly different from non-smoker means. Specifically, we find that the changes in cigarette consumption, CO, and Cotinine are all smaller than
for those classified as non-smokers. However, it is noteworthy that among misreporters we find
significant reductions in CO and Cotinine levels which are relatively closer to non-smokers than
smokers. Moreover, misreporteres saw a threefold increase in BMI relative to smokers with an average gain of about 0.9 BMI units, but an almost 50% smaller increase in BMI than non-smokers.
We also find evidence that misreporters consume nicotine gum at significantly lower rates than
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non-smokers, but also at significantly higher rates than smokers. We have also compared changes
across the same variables after five years and find an even larger decreases in Cotinine level among
misrepoters. Thus, misreporters seem to be descriptively closer to non-smokers than smokers, however, the changes in the smoking variables are all lower than among non-smokers.
Table 22: Changes in Smoking Variables from Baseline to the First Annual
Follow-up Visit for Misreporters Compared to Smokers and Non-Smokers
Variable
Change in BMI
Change in Cotinine
Change in CO (s2)
Change in CO Baseline
Change in Cigarettes
Nicotine Gum
Observations

SI-A
0.89*
(1.60)
-137.72*
(177.91)
-11.17*
(10.86)
-19.95*
(15.99)
-26.76
(12.87)
0.19*
(0.40)
138

SI-P
UC
Non-Smokers
0.95*
0.82*
1.61
(1.45)
(1.15)
(1.66)
-154.38* -270.06
-252.17
(250.82) (365.77)
(240.64)
-17.58
-6.68*
-20.22
(13.66)
(15.63)
(13.72)
-20.95*
N/A
-25.99
(16.00)
N/A
(17.58)
25.66*
-23.83*
-27.95
(14.11)
(16.08)
(14.39)
0.23*
0.15
0.34
(0.42)
(0.36)
(0.47)
130
48
1533

Smokers
0.29
(1.29)
-61.53
(211.95)
-1.96
(13.03)
-8.74
(17.41)
-6.79
(11.95)
0.09
(0.29)
3542

The changes in CO are based on different reference dates. The “s2” refers to changes
from the second screening interview where a few participants were voluntarily tested.
However there are only few observations per group available, 20,17,8,249, and 517, respectively. Baseline refers to the change from the randomization visit where only treatment participants were interviewed. However the sample is significantly larger with
110,105, N/A, 1286, and 1816 observations in each column, respectively. * indicates
that means are significantly different from the means of non-smokers at the 10% level.
The descriptive analysis presents evidence that misreporters reduce cigarette consumption, CO,
and Cotinine levels significantly. However, it is unclear whether those reductions lead to cessation
or just to lower levels of consumption. We calculate a back of the envelope estimate on the level
of miss-classification of misreporters by counting all misreporters whose change in either BMI,
Cotinine or CO level are larger or equal to the mean change for non-smokers. This rough calculation
reveals that 206 misreporters may be in fact non-smokers. However, since many non-smokers
can show high levels of CO and Cotinine due to external influences, such as household smoke
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and nicotine gum use, CO and Cotinine levels may have been elevated at the first examination.
Therefore, we revisit the objective smoking measure in the fifth annual-follow-up visit and find
that 108 of the misreporters are now classified as non-smokers. Since, the intervention and most
changes in the smoking measures persist after five years it is unlikely that many of the misreporters
quit smoking after the first annual follow-up visit. To get a better estimate than the aforementioned
rough missclassifcation calculation our next section models a latent variable framework that tries
to distinguish smokers from non-smokers.

Bayesian Mixture Model
In our second methodological approach we take an agnostic view on whether the objectively verified smoking measure should be preferred to the self-reported smoking measure. Specifically, we
have no prior on whether the objective smoking variable presents the underlying “true” smoking
status. Rather our goal is to identify if the objectively verified smoking variable has information
that will more accurately predict the change in BMI, CO and cotinine levels. Our data is well suited
for such exercise, because the data includes a sample of smokers with a large proportion quitting
smoking after receiving treatment within the first year. Courtemanche et al. (2016) show that
quitting smoking leads to significant weight gain, therefore people misreporting smoking status
should not have experienced a large increase in weight, because they are in reality smokers. On
the other hand, if they quit smoking then they should have experienced significant decreases in CO
and cotinine levels.
We believe that a mixture model is a well suited approach. Broadly, the idea behind the mixture model is to separate a population into subpopulations, where we only use information from the
overall population to make inference about the subspopulation. The approach allows us to derive
properties such as distribution means and probability assignment for each participant to each distribution. In our case, we have a strong smoking cessation treatment that generates an immediate
change in BMI, CO and Cotinine levels, that separates smokers from non-smokers.
Specifically, we apply a Bayesian mixture model (Koop et al. 2007) that implements a latent
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variable framework where it estimates the probability for each individual belonging to each mixture
component. We, generally utilize the objective smoking variable as an “instrument” that assigns
each person to one of the two distributions. Ideally the objective smoking variable helps assign each
smoker to their correct distribution made up of smokers, rather than the distribution of non-smokers
as measured by their BMI, CO and Cotinine levels.
We also estimate the model in levels rather than changes. Since a participant’s demographic
characteristics define a participant’s BMI, and BMI is a stock that evolves over time, we include an
extensive set of control variables that influence the mixture component assignment. For example,
it is important to include gender and age information, because males and older participants weigh
more than their female and younger counterparts. To this end we also include the baseline BMI,
CO, and Cotinine levels to account for the pre-treatment outcome levels where appropriate. The
other explanatory variables are marital status, age, education level, presence of a household smoker,
and nicotine gum use. The general density setup of the mixture model is the following:

p(Yi |Xi , θ) = [1 − Φ(X ′ β)]ϕ(Yi ; µ1 ; σ12 ) + Φ(X ′ β)ϕ(Yi ; µ1 + α; σ22 )

(12)

where the key components of the mixture model are the Y means µ1 and µ1+α and variances σ12 and
σ22 of each mixture component ϕ, respectively. Yi represents the dependent variable for each individual i at the first follow-up visit. The probability of being in each component of the mixture, Φ,
adjusts given the variables summarized in Xi . The mixture assignment probability can be rewritten
in a latent variable framework:

∗

∗

p(Yi |Xi , θ, zi∗ ) = ϕ(Yi ; µ1 ; σ12 )I(zi <0) + ϕ(Yi ; µ1 + α; σ22 )I(zi >0)

(13)

where the latent probability, zi∗ , is determined by the independent variables:

zi∗ = X ′ β + ϵi , ϵi ∼ N (0, 1)

(14)

In this case the latent variable zi∗ has to be greater than zero to include an individual in the sec90

ond mixture component. For example, if Xi includes strong positive predictors suggesting that a
person has a higher BMI, then the latent variable zi∗ will be more likely to have a value greater
than zero. This may result in a separation in the mixture component assignment for differential Xi
characteristics. To complete the model, the following flat prior specifications are included:
µ1 ∼ N (µ, Vµ )
α ∼ N (µα , Vα )
σj2 ∼ IG(ai , bi ), j = 1, 2
[β] ∼ N (µβ , Vβ )
We assume that α is drawn from a normal distribution. To identify the mixture model there has
to be a restriction on either the priors, the mixture component, or the hyper parameters (parameters
in the model besides those defined in the priors or mixture model so far). In this model we restrict
the mean of the second mixture component to be larger than the first component. The joint posterior
distribution for this model is proportional to:

(N
∏[

)
]
∗
∗
ϕ(Yi ; µ1 ; σ12 )I(zi <0) ϕ(Yi ; µ1 + α; σ22 )I(zi >0) ϕ(zi∗ ; X ′ β, 1) × p(β)p(µ1 )p(α)p(σ12 )p(σ12 )

i=1

We estimate the posterior conditionals based on the following specification:

µ1 |θ−µ1 , Bmi ∼ N (Dµ1 dµ1 , Dµ1 )

Dµ1 = (ι′ Σ−1 ι + Vµ−1 )−1

dµ1 = ι′ Σ−1 (Bmi − zα) + Vµ−1 µ)

Note ι is a Nx1 vector of ones, and z is equal to:
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zi = I(zi∗ > 0) and Σ ≡ Diag{(1 − zi )σ12 + zi σ22 }
The mean of the second component of ϕ includes α, and α is drawn from:

α|θ−α , Y ∼ T N(0,∞) (Dα dα , Dα )

Da = (n2 /σ22 + Vα−1 )−1
dα =

N
∑

z(Yi − µ1 )/σ22 + Va−1 µα

i=1

Note that n2 =

∑

i zi

and n1 = N − n2 =

∑

i (1

− zi )

The Betas are drawn from:

β|θ−β , Y ∼ N (Dβ dβ , Dβ )
with Dβ = (X ′ X + Vβ−1 )−1 and dβ = X ′ z ∗ + Vβ−1 µβ
The variances σ12 and σ22 are drawn from:

σ12 |θ−σ12 , Y ∼ IG 

[

n1
+ α1 , b−1
1 + .5
2


σ22 |θ−σ22 , Y ∼ IG 

[

N
∑

n2
+ α2 , b−1
2 + .5
2

]−1 

(1 − zi )(Yi − µ1 )2

i=1

N
∑

]−1 

zi (Yi − µ1 − α)2

i=1

\
Lastly, we draw zi∗ with initially drawing U from a two point distribution U ϵ{0, 1} from:

P r(U = 1) =

[1 − Φ(X ′ β)]ϕ(Yi ; µ1 ; σ12 )
[1 − Φ(X ′ β)]ϕ(Yi ; µ1 ; σ12 ) + Φ(X ′ β)ϕ(Yi ; µ1 + α, σ22 )
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This gives the relative probability of the distribution in the first vs the second component. We
subtract P r(U = 1) from a random variable drawn from the uniform distribution of the interval
(0,1). If the probability of U becomes negative, we draw zi∗ truncated {0, ∞} and vise versa:

zi∗ |U, θ−z∗ , Y




T N

(−∞,0) (X

′

β, 1) if U = 1,



T N(0,∞) (X ′ β, 1)

if U = 0

Lastly, we use hyperparameter values for the priors on µ, α, σj2 and β. Specifically, µ = 5.5, Vµ =
.4, µα = .4, Vα = .4, a1 = a2 = 2, b1 = b2 = 100,µβ = 0kx1 , Vβ = 4I2 . We estimate the model for
10000 iterations and drop the first 2500 simulations.

Mixture Model Results
We present results for six estimations in Table 23 – three mixture models where the dependent
variables are BMI, CO, and Cotinine level, and three models where the dependent variables are
the changes in BMI, CO, and Cotinine level. All models include an extensive set of explanatory
variables as described in the previous section. Table 23 presents posterior means and standard
deviations in parentheses for the first and second mixture components. The average BMI for the
first distribution is 23.21 BMI units, while the second component has an average BMI of about
29 BMI units (µ1 + α). The means are significantly different in each distribution, as measured
by the distance from their standard deviations. Similarly, we find that the model with the change
in BMI as the dependent variable presents two positive means, suggesting that overall participants
gain weight by the first year. Among our estimates including the CO or Cotinine measures, we find
that the first component mean is significantly lower than the second component mean. Moreover,
we find that the estimates utilizing the changes in CO or changes in Cotinine level present first
component means that are negative, indicating a population that decreased CO and Cotinine levels
from the baseline year.
Table 23 does not reveal whether the mixture model assigns smokers correctly to the first mix-
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ture component while assigning non-smokers to the second, higher mixture component. Table 24
reports the posterior probabilities of non-smokers and smokers belonging to each distribution.56 Ex
ante, we expect that smokers are more likely to have a lower BMI, have higher levels of CO and
Cotinine, and also have less changes in BMI units, CO, and Cotinine levels. In other words, we
expect to have more smokers in the first component of the mixture models with the dependent variable measuring BMI and changes in BMI. We expect that because smokers do not change behavior
and therefore do not expect large changes in our dependent variables. On the other hand, we expect
to have more smokers in the second component of in the model with the dependent variables of CO
level, Cotinine level, change in CO level, and change in Cotinine level.
The first panel of Table 24 reveals that the average probability that a non-smoker belongs to the
high BMI distribution is 67%. In contrast, the probability for a smoker to belong to the high BMI
distribution is 47%. Thus, there is is still significant mixture of smokers and non-smokers in the
high BMI distribution. One reason may be that we are missing important explanatory variables that
assigns smokers from non-smokers into each distribution. The second panel presents results for the
distribution probabilities for smokers with the dependent variable measuring the change in BMI.
Here we find a clear separation, smokers and non-smokers belong to the second BMI distribution
with a large gain in BMI, as reported in Table 24, with an average probability of 16% and 97%.
Thus, as previously expected most participants with a large gain in BMI are non-smokers. Across
the other four estimated models we find a similar expected separation of smokers and non-smokers
by distributional means. Those with low levels of CO and Cotinine as well as large decreases in CO
and Cotinine levels are more likely to be non-smokers, while smokers are more likely to belong to
the higher mean CO, and Cotinine distributions and the distributions with smaller changes in CO
and Cotinine levels.
Next, we focus on the distribution assignment of participants that misreport smoking status. As
discussed, those individuals enter the model as smokers and it is of pertinent interest to understand
The Posterior probability of a smoker belonging to the higher distribution (delayed component) is equal to 1 −
Φ(Xβ). Where beta includes the constant and the coefficient on smoking. Similarly, the probability can also be
calculated by dividing the sum of zi by the number of iterations among smokers.
56
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Table 23: Posterior Means and Variance
of all Mixture Models
Dependent Variable BMI (N=5337)
Mean µ1 Mean µ2 Mean σ1 Mean σ2
23.21
28.84
2.49
3.73
(1.68)
(0.75)
(0.53)
(0.73)
Dependent Variable ∆BMI (N=5337)
Mean µ1 Mean µ2 Mean σ1 Mean σ2
0.21
1.56
1.00
1.86
(0.12)
(0.15)
(0.08)
(0.04)
Dependent Variable CO (N=3312)
Mean µ1 Mean µ2 Mean σ1 Mean σ2
4.80
24.12
2.28
13.91
(0.45)
(0.50)
(0.19)
(0.26)
Dependent Variable ∆CO (N=3312)
Mean µ1 Mean µ2 Mean σ1 Mean σ2
-25.63
-8.52
19.12
15.46
(1.01)
(0.94)
(0.39)
(0.81)
Dependent Variable Cotinine (N=5040)
Mean µ1 Mean µ2 Mean σ1 Mean σ2
5.53
275.52
6.52
163.30
(27.89)
(22.08)
(32.64)
(4.36)
Dependent Variable ∆Cotinine (N=5040)
Mean µ1 Mean µ2 Mean σ1 Mean σ2
-136.61 -24.61
293.67
119.28
(7.83 )
(5.63)
(11.75)
(10.14)
Notes: α + µ1 presents the mean of the second mixture component. Standard deviation
in parentheses.
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Table 24: Posterior Probability Assignment to
Lower and Higher Distributions for Smokers
and Non-Smokers at the First Annual Follow-up
Visit
Dependent Variable BMI
Prob. Low BMI
Smoker=1 Smoker=0

Prob High BMI
Smoker=1

Smoker=0

0.53
0.33
0.47
0.67
Dependent Variable ∆BMI
Prob. Low ∆BMI
Prob High ∆BMI
Smoker=1 Smoker=0

Smoker=1

Smoker=0

0.84
0.03
Dependent Variable CO
Prob. Low CO

0.16

0.97

Smoker=1 Smoker=0

Smoker=1

Prob High CO

0.01
0.99
Dependent Variable ∆CO
Prob. Low ∆CO
Smoker=1 Smoker=0

0.99

Smoker=0
0.01

Prob High ∆CO

Smoker=1

Smoker=0

0.08
0.98
0.92
0.02
Dependent Variable Cotinine
Prob. Low Cotinine
Prob High Cotinine
Smoker=1 Smoker=0

Smoker=1

Smoker=0

0.01
0.52
0.99
0.48
Dependent Variable ∆Cotinine
Prob. Low ∆Cotinine
Prob High ∆Cotinine
Smoker=1 Smoker=0
0.33

Smoker=1

Smoker=0

0.67

0.01

0.99
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which mixture component they are most likely part of. For example, if they are in fact smokers,
we suspect that they are assigned with a higher probability to the low BMI and low change in BMI
distribution. However, if those smokers are indeed non-smokers then we expect to find possibly
mixed results, i.e. that a large portion is assigned to the high BMI distribution. Ideally, if the
objective measure corrects for misreporting, then this additional smoking information should help
identify the mixture component assignment. On the contrary, including self-reported smoking information should add more noise into the model because it assumes they are non-smokers while
in fact they are not. In summary, we focus on the distribution assignments of the misreporters to
understand whether they are more likely to be non-smokers than smokers.
Specifically, we analyze how 270 individuals, who self-reported to be non-smokers but the
objective measures indicates that they are smokers, are assigned to the distributions across all six
models.57 Since we only have a sub-sample reporting CO levels, the results reflect estimates among
215 misreporters. Table 25 presents the distribution probabilities for misreporting participants in
all mixture models.
The first panel presents the probability assignment to the BMI distributions. We find an average
probability of belonging to the high BMI distribution of 48%. The second model reveals that misreporters belong to the high change BMI distribution with a probability of 77%. As a result, even
when we utilize the objective smoking variable in the mixture models, there are many misreporters
that belong to the high BMI distribution that is much more likely to consist of non-smokers. However, the probability assignment for the CO and Cotinine level mixture models estimates show that
misreporters are much more likely to be part of smoking distributions with 97% and 99%, respectively. The relatively high levels of CO and Cotinine levels among many smokers and non-smokers
may lead to such an probabilistic assignment. Thus, we concentrate on the changes in CO and Cotinine models that show a similar probability assignment for misreporters to the distributions that
see large changes in the levels. Misreporters have an average probability of being part of the large
decrease in CO and Cotinine distributions with 14% and 42%, respectively. We derive from this
57

46 individuals who are also misreporters have no BMI information in the sample
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result that the objective smoking measure may not necessarily be more accurately measuring true
smoking status. We reiterate that the descriptive statistics and the mixture model estimates suggests
that there is a good amount of misreporters that ”mimic” features of non-smokers.
We proceed by estimating a more sophisticated level of misreporting. Our previous descriptive evidence suggested that 206 misreporters may in fact be not misreporting. We now add an
additional layer of identification. Specifically, we condition on whether any of the 206 participants
have a probability assignment of greater than 90% of belonging to the distributions mostly made
up of non-smokers as defined by mixture models. For simplicity, we count how many misreporters
belong to the high change in BMI distribution, low change in CO distribution and low change in Cotinine distributions. As an example, Figure 9 presents the probability assignment for misreporters
to the high change in BMI distribution. Our final new calculation finds that between 68 and 109
misreporters may in fact be not misreporting smoking status.58 Thus this indicates that depending
on the sample used, between 26% and 51% of misreporters may not be misreporting.
Nevertheless, it is possible that most of the misreporters only reduced cigarette consumption,
but never quit completely. We argue that this is only of limited concern, because there is ample
evidence that many of the misreporters are in fact non-smokers. By the second annual follow-up
95 of the misreporters are objectively classified as non-smokers. It is unlikely that all of them quit
in year two, because there was no smoking cessation treatment or hospital support after the first
four months. Instead, we believe that it is more likely that most of them are misclassified, because
there were no objective clinical measures that clearly separated non-smokers from smokers – as
reported in Figure 9.
58
Each separate calculation finds that 109 misreporters in the low CO change distribution, 78 in the high BMI change
distribution and 68 in the low change Cotinine distribution satisfy the criteria.
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Table 25: Posterior Probability Assignment
to the Lower and Higher BMI Component
for Misreporters in each Model
Dependent Variable BMI (N=270)
Prob. Low BMI
Prob High BMI
Misreporting=1

Misreporting=1

0.52
0.48
Dependent Variable ∆BMI (N=270)
Prob. Low ∆BMI
Prob High ∆BMI
Misreporting=1

Misreporting=1

0.23
0.77
Dependent Variable CO (N=215)
Prob. Low CO
Prob High CO
Misreporting=1

Misreporting=1

0.03
0.97
Dependent Variable ∆CO (N=215)
Prob. Low ∆CO
Prob High ∆CO
Misreporting=1

Misreporting=1

0.14
0.86
Dependent Variable Cotinine (N=263)
Prob. Low Cotinine
Prob High Cotinine
Misreporting=1

Misreporting=1

0.01
0.99
Dependent Variable ∆Cotinine (N=263)
Prob. Low ∆Cotinine Prob High ∆Cotinine
Misreporting=1

Misreporting=1

0.42

0.58
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Figure 9: Posterior Probability of All Misreporting Participants Belonging to the Higher
Mean Change BMI Distribution

In summary, our Bayesian mixture model approach utilizing information on BMI, CO, and Cotinine level presents evidence that smokers belong to a different distribution than non-smokers in
all measures. Moreover, we find that a significant portion of the misreporters have a high probability of belonging to the distribution made up of mostly non-smokers. In the end we estimate that
about 30% to 50% of misreporters may in fact be not misreporting smoking status. We believe that
this finding shows the importance of accounting for misreporting and we believe that descriptive
evidence and the mixture model approach allows researchers to identify “true” misreporters.

Conclusion
This paper provides new evidence to several questions regarding misreporting in self-reported
smoking information. Descriptive statistics show that smoking cessation treatment group partici100

pants misreport twice as much as participants in the control group. We suspect that being in the
treatment group contributes to the higher rate of misreporting by treatment group assignment. It is
also conceivable that the participant’s perception of being treated to achieve a personal and socially
desirable outcome magnifies the misreporting level.
Our results indicate that being male, married, and of older age increases the probability of
misreporting significantly. Our preferred estimates suggest that being male and married increases
the probability of misreporting by about 10 percentage points. Sub-sample analyses by treatment
group show that the relationship between demographic characteristics and misreporting is larger in
the treatment groups than in the control group.
We also provide evidence that the objectively verified smoking measure may not be necessarily
“better” compared to the self-reported smoking measure. In our second methodological approach
we take an agnostic view on whether participants classified as misreporters are in fact misreporting
smoking status. We utilize BMI, CO and Cotinine level information to inform if someone is a
smoker and focus on those classified as misreporters. We apply a two distribution mixture model
and our estimates suggest that there are two separate distributions. For example, our results indicate
that when we model the two distributions of changes in BM, from the pre-treatment BMI level to
the first annual follow-up visit, that the high change in mean BMI distribution is mostly made up
of non-smokers. Based on descriptive evidence and the mixture model results, we believe that
at least 30% of misreporters may in fact not be misreporting smoking status, reaching as high as
50%. Moreover, our results imply that common explanatory variables can help reveal wrongly
misreported smoking participation in a mixture model framework.
Our results also have implications for the smoking literature. We show that participants who
receive a smoking cessation treatment misreport at higher levels than in the control group. It is
possible that the knowledge or perception of treatment may also occur in government programs.
One such treatment could be a state’s cigarette tax increase. If smokers are aware of a tax increase
they may be more likely to under-report smoking participation in survey responses. In this case,
the negative correlation between state cigarette taxes, and smoking participation may be overstated.

101

As a result, claims that higher taxes reduce smoking participation should be revisited.
We also provide evidence on the level of misreporting in smoking. We find relatively low levels of under-reporting in our adult sample. Clinicians classify 8% of self-reported non-smokers as
smokers. Evidence from RCTs presents under reporting smoking levels up to 35% among pregnant
women. Additionally, we find no evidence of over-reporting smoking participation. We conclude
that under-reporting of smoking participation is significantly lower than in other studies. Additionally, we find evidence suggesting that a significant portion of misreporters may in fact not
be misreporting their status at all. Thus, misreporting levels may in fact be even lower than the
reported 8%.
Lastly, we provide evidence that can be relevant for the methodological literature addressing
misreporting. We find that misreporting is endogenous along different demographic dimensions.
Our results provide a benchmark to identify which characteristics need to be controlled for to
achieve exogenous misreporting, a condition required by many papers to recover unbiased estimators. We also question the validity of estimators relying on exogenous misreporting if they
cannot account for the demographic characteristics that affect misreporting, such as the presence
of additional household smokers.
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Appendix To Chapter I
Table A1: Cigarette Consumption per Day and Smoking Status by
Month Prior to the First Annual Follow-up Visit
By Month
Mean Smokers
12 Months Before Visit
0.88
(0.32)
11 Months Before Visit
0.79
(0.40)
10 Months Before Visit
0.70
(0.46)
9 Months Before Visit
0.63
(0.48)
8 Months Before Visit
0.62
(0.48)
7 Months Before Visit
0.63
(0.48)
6 Months Before Visit
0.65
(0.47)
5 Months Before Visit
0.66
(0.47)
4 Months Before Visit
0.66
(0.47)
3 Months Before Visit
0.66
(0.47)
2 Months Before Visit
0.67
(0.47)
1 Month Before Visit
0.68
(0.46)

Mean Cigarettes per Day
26.77
(16.99)
22.54
(17.56)
18.53
(17.20)
16.00
(16.66)
15.62
(16.50)
15.76
(16.37)
16.02
(16.19)
16.11
(16.05)
16.21
(15.97)
16.27
(15.95)
16.27
(15.93)
16.23
(15.76)

Standard errors are in parenthesis. Columns 2 presents an average smoking status for a binary variable in each months. Column 3 presents selfreported average cigarette consumption in each month.
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Table A2: The Effect of the Length of Abstaining from
Smoking on Alcoholic Beverage Consumption at the First
Annual Follow-up Visit
Dep. Var. Drinks per Week
Length of Non-Smoking
12 Months Sustained Non-Smoker
11 Months Sustained Non-Smoker
10 Months Sustained Non-Smoker
9 Months Sustained Non-Smoker
8 Months Sustained Non-Smoker
7 Months Sustained Non-Smoker
6 Months Sustained Non-Smoker
5 Months Sustained Non-Smoker
4 Months Sustained Non-Smoker
3 Months Sustained Non-Smoker
2 Months Sustained Non-Smoker
1 Month Sustained Non-Smoker

OLS
-1.251***
(0.403)
-0.614
(0.451)
-0.578
(0.356)
-0.587
(0.360)
-0.284
(0.549)
-0.770
(0.958)
-0.232
(1.042)
0.522
(1.438)
0.346
(1.105)
-2.003**
(0.785)
-1.963***
(0.718)
0.298
(0.926)

2SLS
-1.183***
(0.428)
-0.695
(0.454)
-0.571
(0.363)
-0.630*
(0.370)
-0.112
(0.588)
2.096***
(0.676)
-0.958
(1.306)
1.249
(2.160)
89.03
(73.67)
-0.626
(1.188)
-2.812
(0.616)
0.049
(1.263)

Robust standard errors are in parenthesis. ***,**, and * indicate
significance at the 1, 5, and 10 percent level. Columns 2-3 present
OLS and 2SLS estimates for a binary variable equal to one if a person
becomes a sustained quitter for the rest of the year and zero for a
continuous smokers. Each row entry presents a separate marginal
effect.
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Table A3: The Effect of the Length of Abstaining from
Smoking on Alcoholic Beverage Consumption at the First
Annual Follow-up Visit
Dep. Var.Drinks per Week
Length of Non-Smoking
12 Months Sustained Non-Smoker
11 Months Sustained Non-Smoker
10 Months Sustained Non-Smoker
9 Months Sustained Non-Smoker
8 Months Sustained Non-Smoker
7 Months Sustained Non-Smoker
6 Months Sustained Non-Smoker
5 Months Sustained Non-Smoker
4 Months Sustained Non-Smoker
3 Months Sustained Non-Smoker
2 Months Sustained Non-Smoker
1 Month Sustained Non-Smoker

NB
-1.49***
(0.479)
-0.769
(0.484)
-0.557
(0.375)
-0.558
(0.383)
-0.225
(0.553)
-0.786
(1.02)
-0.288
(1.034)
0.122
(1.26)
0.114
(1.105)
-2.06*
(1.21)
-2.749**
(1.18)
0.017
(0.860)

CF-NB
-1.39**
(0.548)
-0.862*
(0.497)
-0.572
(0.383)
-0.608
(0.398)
-0.076
(0.575)
-2.62***
(1.00)
-0.892
(1.46)
0.617
(1.69)
-0.048
(1.47)
-0.404
(1.49)
-5.01***
(1.63)
-0.30
(1.35)

Robust standard errors are in parenthesis. ***,**, and * indicate
significance at the 1, 5, and 10 percent level. Columns 2-3 represent Negative Binomial and Control function approach Negative
Binomial marginal effects for a binary variable equal to one if a
person becomes a non-smoker for the rest of the year and zero for
a continuous smokers. Each row entry presents a separate average
marginal effect.
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Table A4: The Effect of the Length of Abstaining from Smoking on Current
Alcohol Consumption at the First Annual Follow-up Visit
Female
Length of Non-Smoking
12 Months Sustained Non-Smoker
11 Months Sustained Non-Smoker
10 Months Sustained Non-Smoker
9 Months Sustained Non-Smoker
8 Months Sustained Non-Smoker
7 Months Sustained Non-Smoker
6 Months Sustained Non-Smoker
5 Months Sustained Non-Smoker
4 Months Sustained Non-Smoker
3 Months Sustained Non-Smoker
2 Months Sustained Non-Smoker
1 Month Sustained Non-Smoker

Male

NB
CF-NB
NB
-1.983*** -2.127***
-1.142*
(0.538)
(0.614)
(.683)
-1.170*
-1.286**
-0.567
(0.632)
(0.661)
(0.641)
-0.399
-0.528
-0.751
(0.449)
(0.467)
(0.539)
-0.198
-0.298
-0.931*
(0.475)
(0.513)
(0.547)
-0.0263
-0.245
-0.349
(0.675)
(0.738)
(0.765)
0.112
-3.729**
-1.437
(1.478)
(1.813)
(1.250)
-1.460
-0.642
0.358
(1.353)
(1.780)
(1.382)
-1.494
-65.52***
0.911
(1.681)
(4.437)
(1.657)
0.226
0.472
-0.211
(1.167)
(1.944)
(1.687)
0.0982
0.093
-4.392***
(1.117)
(1.923)
(1.928)
-3.086*** -4.274***
-2.023
(0.802)
(1.249)
(1.862)
-1.730
-1.520
0.661
(1.577)
(2.294)
(1.047)

CF-NB
-0.882
(0.790)
-0.658
(0.652)
-0.629
(0.544)
-0.936*
(0.557)
0.0276
(0.775)
-2.395**
(1.215)
-0.961
(2.006)
1.584
(1.907)
-0.571
(1.803)
-1.264
(1.549)
-5.139*
(2.817)
0.580
(1.536)

This table presents presents Negative Binomial and Negative Binomial with control function approach average marginal effects for a binary indicator equal to one for a person
becoming a sustained non-smoker in a month and zero if he is continuous smoker. This is
a supplement for Table 8 presenting OLS and 2SLS results.
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Appendix To Chapter II
Table A5: Sensitivity of Estimates to Different BMI Depreciation Rates

δ=0

δ = 0.05

δ = 0.1

δ = 0.15

δ = 0.2

δ = 0.25

δ = 0.30

N

(IV With Year 5 BMI Only)
Long Run (BMI Year 5)
Average Average Average
Quit
Cigarettes
CO
∗∗∗
∗∗∗
2.646
-0.065
-0.082∗∗∗
(0.285)
(0.007)
(0.011)
[1.91]
[1.81]
∗∗∗
∗∗∗
2.675
-0.066
-0.083∗∗∗
(0.288)
(0.007)
(0.011)
[1.94]
[1.83]
∗∗∗
∗∗∗
2.706
-0.067
-0.084∗∗∗
(0.291)
(0.007)
(0.011)
[1.97]
[1.86]
∗∗∗
∗∗∗
2.738
-0.068
-0.086∗∗∗
(0.294)
(0.008)
(0.011)
[2.00]
[1.89]
2.772∗∗∗ -0.069∗∗∗ -0.088∗∗∗
(0.297)
(0.008)
(0.011)
[2.03]
[1.93]
2.808∗∗∗ -0.070∗∗∗ -0.089∗∗∗
(0.300)
(0.008)
(0.011)
[2.07]
[1.96]
∗∗∗
∗∗∗
2.844
-0.072
-0.091∗∗∗
(0.304)
(0.008)
(0.012)
[2.10]
[2.00]
5446
4966
4517

See notes for Table 2.
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Figure A1: Semi-Parametric Graphs of Long-Run Effects of Simple Average Cigarettes per
Day on BMI for Education and Age Subsamples
Some College

College Graduate
30
28
BMI
26

BMI
26

24

24

0

10

20
30
40
Cigarettes per Day

95% CI

50

22

22

22

24

BMI
26

28

28

30

30

High School

0

Predicted BMI

10

20
30
40
Cigarettes per Day

95% CI

Predicted BMI

20
30
40
Cigaretttes per Day

95% CI

50

Predicted BMI

20
30
40
Cigarettes per Day

95% CI

50

Predicted BMI

30

30

BMI
26

28

28

24

24

22

22

10

10

Age: 55 and above

BMI
26

28
BMI
26
24
22

0

0

Age: 45 to 55

30

Age: Under 45

50

0

10

20
30
40
Cigarettes per Day

95% CI

108

50

Predicted BMI

0

10

20
30
40
Cigarettes per Day

95% CI

50

Predicted BMI

Figure A2: Semi-Parametric Graphs of Long-Run Effects of Simple Average Cigarettes per
Day on BMI for Gender and Baseline BMI Subsamples
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Figure A3: Semi-Parametric Graphs of Long-Run Effects of Simple Average CO on BMI
for Education and Age Subsamples
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Figure A4: Semi-Parametric Graphs of Long-Run Effects of Simple Average CO on BMI
for Gender and Baseline BMI Subsamples
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Table A6: Regression Estimates for Treatment Group 1 (SIA) Subsample
Dependent Variable: Misreporting Smoking Status
Male
Education
Married
AGe
BMI
Nicotine Gum

0.0764***
(0.0261)
-0.00541
(0.00441)
0.00103
(0.0281)
0.00485**
(0.00199)
-0.0118***
(0.00316)
-0.116***
(0.0244)

HH Smoker

0.0757***
(0.0261)
-0.00610
(0.00446)
0.00311
(0.0280)
0.00488**
(0.00199)
-0.0116***
(0.00316)
-0.118***
(0.0245)
-0.0347
(0.0276)

# HH Smokers

0.0761***
(0.0262)
-0.00577
(0.00444)
0.00278
(0.0281)
0.00491**
(0.00199)
-0.0117***
(0.00316)
-0.117***
(0.0245)

0.0772***
(0.0261)
-0.00585
(0.00442)
0.00819
(0.0283)
0.00483**
(0.00198)
-0.0117***
(0.00317)
-0.119***
(0.0247)

0.0786***
(0.0261)
-0.00532
(0.00438)
0.00904
(0.0283)
0.00472**
(0.00198)
-0.0118***
(0.00316)
-0.119***
(0.0247)

0.0792***
(0.0261)
-0.00541
(0.00437)
0.00552
(0.0286)
0.00473**
(0.00198)
-0.0120***
(0.00316)
-0.118***
(0.0247)

-0.0508
(0.0327)

-0.0548*
(0.0326)
0.0384
(0.0412)

-0.0149
(0.0208)

HH Spouse Smokes

Constant

0.299*
(0.157)

0.312*
(0.159)

0.304*
(0.158)

0.309*
(0.158)

0.304*
(0.157)

-0.0524
(0.0325)
0.0430
(0.0413)
-0.0995*
(0.0595)
0.313**
(0.157)

Observations
R-squared

804
0.051

804
0.052

804
0.051

804
0.053

804
0.054

804
0.056

HH Child Smokes
HH Other Smokes

Notes: Regressions include Heteroscedasticity robust standard errors in parentheses.
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Table A7: Regression Estimates for Treatment Group 2 (SIP) Subsample
Dependent Variable: Misreporting Smoking Status
Male
Education
Married
Age
BMI
Nicotine Gum

0.0628**
(0.0265)
0.00208
(0.00481)
0.0473*
(0.0261)
0.00146
(0.00187)
-0.00874***
(0.00321)
-0.0525**
(0.0261)

HH Smoker

0.0631**
(0.0265)
0.00215
(0.00482)
0.0473*
(0.0262)
0.00146
(0.00188)
-0.00876***
(0.00322)
-0.0519**
(0.0263)
0.00782
(0.0304)

# HH Smokers

0.0631**
(0.0265)
0.00224
(0.00483)
0.0474*
(0.0262)
0.00147
(0.00187)
-0.00873***
(0.00321)
-0.0516**
(0.0262)

0.0631**
(0.0265)
0.00217
(0.00483)
0.0454*
(0.0266)
0.00144
(0.00187)
-0.00873***
(0.00321)
-0.0504*
(0.0264)

0.0644**
(0.0266)
0.00236
(0.00483)
0.0447*
(0.0266)
0.00149
(0.00187)
-0.00876***
(0.00321)
-0.0503*
(0.0264)

0.0646**
(0.0268)
0.00234
(0.00484)
0.0419
(0.0271)
0.00146
(0.00188)
-0.00871***
(0.00321)
-0.0498*
(0.0263)

0.0233
(0.0383)

0.0209
(0.0380)
0.0411
(0.0505)

0.0123
(0.0239)

HH Spouse Smokes

Constant

0.228
(0.151)

0.225
(0.151)

0.221
(0.151)

0.225
(0.151)

0.217
(0.150)

0.0208
(0.0382)
0.0419
(0.0507)
-0.0325
(0.0602)
0.220
(0.152)

Observations
R-squared

792
0.024

792
0.024

792
0.024

792
0.024

792
0.025

792
0.026

HH Child Smokes
HH Other Smokes

Notes: Regressions include Heteroscedasticity robust standard errors in parentheses.
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Table A8: Regression Estimates for Control Group (UC) Subsample
Dependent Variable: Misreporting Smoking Status
Male
Education
Married
Age
BMI
Nicotine Gum

0.0567
(0.0513)
0.00516
(0.00936)
0.0647
(0.0476)
0.00588*
(0.00317)
-0.00657
(0.00617)
0.131
(0.101)

HH Smoker

0.0524
(0.0523)
0.00498
(0.00937)
0.0707
(0.0491)
0.00580*
(0.00317)
-0.00694
(0.00609)
0.129
(0.101)
-0.0389
(0.0589)

# HH Smokers

0.0504
(0.0526)
0.00528
(0.00939)
0.0744
(0.0496)
0.00586*
(0.00316)
-0.00719
(0.00606)
0.133
(0.101)

0.0468
(0.0515)
0.00723
(0.00934)
0.0917*
(0.0504)
0.00630**
(0.00315)
-0.00700
(0.00606)
0.143
(0.0997)

0.0508
(0.0531)
0.00789
(0.00921)
0.0880*
(0.0507)
0.00638**
(0.00316)
-0.00630
(0.00612)
0.143
(0.1000)

0.0514
(0.0530)
0.00815
(0.00927)
0.0910*
(0.0504)
0.00656**
(0.00319)
-0.00625
(0.00614)
0.146
(0.100)

-0.144**
(0.0669)

-0.157**
(0.0663)
0.0640
(0.0927)

-0.0421
(0.0503)

HH Spouse Smokes

Constant

-0.127
(0.272)

-0.102
(0.268)

-0.101
(0.267)

-0.158
(0.270)

-0.195
(0.270)

-0.157**
(0.0665)
0.0659
(0.0930)
0.0627
(0.139)
-0.213
(0.271)

Observations
R-squared

207
0.046

207
0.048

207
0.050

207
0.063

207
0.065

207
0.066

HH Child Smokes
HH Other Smokes

Notes: Regressions include Heteroscedasticity robust standard errors in parentheses.
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